A study of the rabbit eye test system to determine the activity of acidic non-steroidal anti-inflammatory agents by Wiseman, Ian Charles
A STUDY OF 
THE RABBIT EYE TEST SYSTEM TO DETERMINE 
THE ACTIVITY OF ACIDIC NON-STEROIDAL 
ANTI-INFLAMMATORY AGENTS 
A thesis presented for the degree of 
MASTER OF SCIENCE 
at Rhodes University 
by 
IAN CHARLES WISEMAN 
January 1977 
ACKNOWLEDGEMENTS 
I wish to thank: 
PROFESSOR E. RAMSTAD 
PROFESSOR B. POTGIETER 
AND MR L. PATON 
DR J.L. STRAUGHAN 
. MR D. SHARWOOD 
DR A.L.C. HOFMEYR 
S.A. I.M.R. 
MR J. HANDSFORD 
M.S.D. (PTY) LTD. 
ClBA-GEIGY (PTY) LTD. 
PARKE-DAVIS LABS (PTY) LTD 
for supervising this project 
and for their guidance and 
encouragement. 
for directing me in the 
technique used on the rabbit 
eye. 
for the statistical evaluation 
of the results. 
for the preparation and inter= 
pretation of the histological 
slides used. 
for performing the protein 
determinations on aqueous 
humour. 
for photographic work performed 
for drug samples and literature 
supplied . 
M.S.D. (PTY) LTD. 
ClBA-GEIGY (PTY) LTD. 
MRS P.R. COATES 
MY LECTURING COLLEAGUES 
for financial assistance 
towards this work. 
for typing this manuscript 
for their help and 
encouragement. 
CHAPTER 1 
1.1 
1.2 
1.3 
1. 3.1 
1. 3.2 
1. 3. 3 
1.3.4 
1. 3.5 
1. 3. 6 
1. 3. 7 
1. 3. 8 
CHAPTER 2 
2.1 
2.2 
2.2.1 
2.2.2 
2.2.3 
CONTENTS 
INTRODUCTION 
The Inflammatory Reaction 
Description and Definition 
Cardinal Signs 
The Vascular Response 
Exudation and Swelling 
Chemotaxis 
The Chemical Mediators of Inflammation 
Stages in the Development of Inflammation 
Intra-ocular Inflammation 
Intra-ocular Pressure 
Physiological Variations in I.O.P. 
Review of Methods for the Detection and 
Evaluation of New Acidic Non-steroidal 
Anti-inflammatory Agents 
Screening Procedures 
Method (1) 
Method (2) 
Method (3) 
PAGE 
1 
3 
3 
3 
5 
6 
7 
7 
8 
9 
10 
11 
13 
13 
13 
14 
14 
15 
2 . 3 
2.3.1 
2.3.2 
2.3 . 3 
2. 3.4 
2.4 
2.4.1 
2 . 4.2 
2.4.3 
2.5 
2.6 
2.6.1 
2.6 . 2 
2.6 . 3 
2.7 
CHAPTER 3 
3 . 1 
3. 2 
3.3 
3.3.1 
3.3.2 
An "Ideal" Screening Programme 
Acute Inflammatory Models 
Chronic-Inflammatory Models 
Assessment of Relevant Ancillary 
Activities 
Essential Features of a Test System 
The TWo Assay Procedures used in this 
Stu~y 
The Rat-paw-oedema Method 
Methodology 
Results 
Disadvantages of the Rat-paw Method of 
Oedema 
The Rabbit-eye-test System as a Method 
of Assay 
Method 
Results 
Aqueous Protein 
Summary 
Inflammatory Agents 
Carrageenan as an Inflammagen 
Arachidonic Acid as an Inflammagen 
History 
Biosynthesis 
PAGE 
15 
16 
16 
16 
16 
17 
17 
17 
18 
20 
20 
21 
21 
21 
22 
23 
23 
25 
25 
27 
3 . 3.3 
3.3.4 
3.3.5 
3 . 3.6 
3 . 4 
CHAPTER 4 
4.1 
4. 1.1 
4.1. 2 
4.1.3 
4.1.4 
4.1.5 
4.1.6 
4.2 
4.3 
4 . 4 
4.5 
4.6 
Mechanism of Action of Prostaglandins 
The Role of Prostaglandins in Ocular 
Inflammation 
Prostaglandin Effect on Intra-ocular 
Pressure 
The Role of Prostaglandins in the 
Carrageenan-induced Inflammatory 
Response in the Rat Paw 
Swmnary 
PAGE 
28 
29 
31 
31 
32 
Chemistry of Acidic Non-steroidal Anti- 34 
Inflammatory Agents 
Defini tion 34 
Receptor Site 34 
Acidic Non-steroidal Anti-inflammatory 35 
Agents and Preformed Prostaglandins 
Inhibition of Prostaglandin Synthesis 36 
Prostaglandin-synthetase Inhibitors 37 
Chemical Structures of the Acidic 38 
Non-steroidal Anti- inflammatory 
Compounds evaluated 
Indomethacin 40 
Diclofenac sodium 41 
Flufenamic acid 42 
Sulindac 42 
Summary 43 
CHAPTER 5 
5.1 
5.2 
5 . 3 
5.4 
5.5 
5.6 
5.7 
5 . 8 
5.8.1 
5.8.2 
5 . 9 
5.9.1 
5.9.2 
5.9 . 3 
5 . 9.4 
5.9.5 
5 . 10 
5 . 11 
5.12 
5 . 13 
5.14 
5 . 15 
5.16 
Experimentation 
Considerations 
Aims and Preliminary 
Inflammatory Response 
Measurement of Intra-ocular Pressure 
Protein Determination 
Measurement of Rat Paw Volume 
Method of Anaesthetization 
Experimental Animals 
Experimental - Materials and Method 
Rabbit Eye The Test System 
Aspiration of the Eye 
Preparation of the Materials 
Sodium Arachidonate 
Indomethacin 
Flufenamic Acid 
Diclofenac sodium 
Sulindac 
The Anaesthetic 
The Mackay-Marg Tonometer 
Amplifier-Recorder 
Calibration of Tonometer 
Paper Speed 
Tonometer Scale 
Probe Application 
PAGE 
44 
44 
45 
45 
45 
45 
46 
46 
46 
47 
48 
48 
49 
49 
49 
49 
49 
50 
50 
51 
51 
51 
51 
PAGE 
5.17 Analysis of the Tonogram 52 
5.18 Protein-Determination Procedure 54 
5.18.1 Method 54 
5.19 The Rat Paw Oedema Method of Assay 54 
5.19.1 Method 54 
5.19.2 Method of Measuring Foot Volume 56 
5.20 Summary 57 
CHAPTER 6 Results 58 
Conclusion 
Summary 
References 
Appendix I Photographs of 
procedures used 
Appendix II Histological 
observations 
Appendix III Histological 
observations 
Appendix IV Histological 
observations 
79 
81 
83 
91 
93 
95 
97 
Table 1 
Table II 
Table III 
Table IV 
Table V 
Table VI 
ILLUSTRATIONS AND GRAPHS 
INDEX 
Inhibitory effects of indomethacin on 
the action of topically instilled sodium 
arachidonate 
Inhibitory effects of diclofenac sodium 
on the action of topically instilled 
sodium arachidonate 
Inhibitory effects of flufenamic acid 
on the action of topically instilled 
sodium arachidonate 
Inhibitory effects of sulindac on the 
action of topically instilled sodium 
arachidonate 
Inhibition of carrageenan-induced oedema 
in the rat paw by indomethacin 
Inhibition of carrageenan- induced oedema 
in the rat paw by diclofenac sodium 
Table VII Inhibition of carrageenan-induced oedema 
in the rat paw by flufenamic acid 
Table VIII Inhibition of carrageenan-induced oedema 
in the rat paw by sulindac 
59 
61 
63 
65 
67 
69 
71 
73 
Fig. 1 
Fig. 2 
Fig. 3 
Fig. 4 
Fig. 5 
Fig. 6 
Fig. 7 
Fig. 8 
Fig . 9 
Fig. 10 
Fig. 11 
Fig. 12 
Scheme of inflammation 
Structures involved in the formation and 
drainage of aqueous humour 
Volume-time curve of developing oedema in 
the rat paw 
Biosynthetic Pathway of Prostaglandins. 
A hypothetical receptor-outline for anti-
inflammatory agents 
Configuration of Indomethacin as proposed to 
fit a hypothetical anti-inflammatory receptor 
A possible conformation of PGE2 compared with 
indomethacin 
The mechanism of action of the ANSAI drugs 
Graph showing 1. O. P. readings in rabbi ts pre-
treated with indomethacin 
Graph showing I.O.P. readings in rabbits pre-
treated with dic10fenac sodium 
Graph showing I.O.P. readings in rabbits pre-
treated with f1ufenamic acid 
4 
11 
19 
27 
34 
35 
35 
40 
60 
62 
64 
Graph showing I.O.P. readings with rabbits pre- 66 
treated with su1indac 
Fig. 13 
Fig. 14 
Fig. 15 
Fig. 16 
Fig. 17 
Fig. 18 
Fig. 19 
Fig. 20 
Graph showing paw mass readings in the rats 
pre-treated with indomethacin 
Graph showing paw mass readings in the rats 
pre-treated with diclofenac sodium 
Graph showing paw mass readings in the rats 
pre-treated with flufenamic acid 
Graph showing paw mass readings 'n the rats 
pre-treated with sulindac 
Percentage inhibition of intra-ocular pressure 
after pre-treatment with ANSAI compounds 
Percentage inhibition of carrageenan-induced 
oedema in the rat paw after pre-treated with 
ANSAI compounds 
A comparison of the protein content of the aqueous 
humour after pre-treatment with ANSAI compounds 
Comparison of the two test systems. 
68 
70 
72 
74 
74 
75 
75 
76 
77 
78 
A STUDY OF THE RABBIT EYE TEST SYSTEM TO DETERMINE 
THE ACTIVITY OF ACIDIC NON-STEROIDAL 
ANTI - INFLAMMATORY AGENTS 
INTRODUCTION: 
"Inflammation per se, has been defined sufficiently to 
permit a rational approach to the search for drugs that 
modify this process, but satisfactory animal models for 
most rheumatoid diseases are not available". (Swingle 1974) 
In the search for new meaningful procedures for the 
detection and evaluation of anti-inflammatory drugs, the 
rabbit eye as a test system was studied. 
In designing a laboratory test system to detect new acidic 
non-steroidal anti-inflammatory (ANSAI) compounds, it is 
necessary to define which component in the inflammatory 
process is to be suppressed. This is necessary as there 
does not appear to be a non-steroidal anti-inflammatory 
agent capable of suppressing all the components of both 
the acute and chronic inflammatory responses.. (Spector & 
Willoughby 1968). 
In the rabbit-eye-test system, the exudation phase is the 
event in the inflammatory process which is modified, while 
in the rat paw oedema method of assay, the inhibition of 
swelling (oedema) is the parameter measured. 
REASON FOR CHOOSING THE RABBIT EYE AS A TEST SYSTEM: 
It is known that prostaglandin-like substances are present 
in ocular tissues (Ambache & Brummer 1968) and low 
1 
concentrations thereof administered either into the 
anterior chamber or onto the cornea cause changes to 
occur, that are associated with ocular inflammation~ 
(Beitch & Eakins 1969), (Eakins 1970), (Kelly & Starr 
1971), (Starr 1971), (Bethel & Eakins 1972 ) 
This observation led to the suggestion that substances 
which inhibit the action or synthesis of prostaglandins 
might be of value in counteracting ocular inflammation. 
(Eakins et al., 1972 ). It was shown by 
Bhattacherjee & Eakins (1974) that indomethacin produces 
an in vitro inhibition of the prostaglandin synthetase 
system in ocular tissues. Later, Bhattacherjee (1975) 
in an in vivo study, demonstrated the suppressive effects 
of indomethacin on the inflammatory response in the 
rabbit eye brought about by Shigella. endotoxin. 
Arachidonic acid, the precursor of prostaglandins, was 
subsequently used by Bhattacherjee & Eakins (1975) to 
produce an inflammatory response in the rabbit eye. 
This inflammatory response was shown to be inhibited by 
pretreatment with non-steroidal anti-inflammatory 
compounds. 
Straughan (1975), using arachidonic acid to induce the 
inflammatory response, tested the anti-inflammatory 
effects of a number of ANSAI compounds in this manner. 
It is the purpose of the present investigation to examine 
the possibility of using the rabbit eye test system for the 
detection and evaluation of acidic non-steroidal anti-
inflammatory agents, by comparing it with the classical 
rat-paw method of assay (Winter Risley and Nuss 1962). 
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CHAPTER 1 
1.1 THE INFLAMMATORY REACTION 
Acute inflammation has been regarded as a mechanism 
serving to protect the individual from a wide range of 
hazards. However, it is sometimes difficult to accept 
the concept of crippling inflammatory diseases as being 
part of such life-preserving mechanisms. 
1.2 DESCRIPTION AND DEFINITION 
The inflammatory process is considered by Hicks (1975) 
to be a protective function, designed to minimise or 
eliminate the cause of damage and, subsequently, to 
remove damaged tissue and lead to its repair. 
Walter and Israel (1974) proposed the following definition: 
"Inflammation is the reaction of the vascular and 
supporting elements of a tissue to injury, and results in 
the formation of a protein-rich exudate, provided the 
injury has not been so severe as to destroy the area". 
1.3 CARDINAL SIGNS 
The five cardinal signs of acute inflammation are: heat 
(calor); redness (rubor); pain (dolor); swelling (tumour); 
and loss of function. These signs and symptoms reveal 
changes in the vascular supply to the area and are brought 
about by a number of local hormonal mediators. 
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FIG.1. OPERATIONAL SCHEME OF THE MULTI-MEDIATED INFLAMMATORY REACTION 
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1.3.1 
Walter and Israel subdivide the acute inflammatory 
reaction as follows: 
THE VASCULAR RESPONSE 
The changes that take place in blood vessels are the 
most obvious signs of acute inflammati.on. 
(i) Changes in the calibre of blood vessels 
There is an initial constriction in response to 
trauma, causing blanching of the area, followed 
by a persistent vasodilation. The vasodilation 
results in an increased blood flow to the affected 
area, and a marked increase in the redness ("rubor") 
of the area occurs. This rapid spread of erythema 
is called a "flare". The "calor", or heat, 
associated with inflammation is seen in parts near 
the body surface - skin, face, ears and fingers. It 
is not a feature of internal inflammation. 
Cohnheim (1889). 
(ii) Changes in the vessel wall and flow of blood 
The arteriolar dilation causes an increase in blood 
velocity followed by a slowing of the stream and 
finally stasis. The main factor in the production 
of stasis is that the increase in the vascular 
permeability causes fluid to be lost from the blood 
which in turn becomes more viscid. In addition, 
the cross-section in the effective vascular bed 
increases hence the pressure decreases and 
l .eucocyte adherence takes place, a phenomenon which 
is highly characteri.stic of damage to blood vessels. 
The leucocytes line the endothelium, the phenomenon 
being known as margination of the white cells or 
pavementing of the endothelium. The endothelium 
itself undergoes change and a swelling of the 
endothelium cells can be seen. 
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1.3.2 EXUDATION AND SWELLING 
(i) The fluid exudate 
Acute inflammation is characterised by the 
formation of an exudate. There are possibly four 
mechanisms involved in the production of the fluid 
exudate: 
(a) Increased vascular permeability to proteins; 
(b) Increased capillary blood pressure; 
(cl A breakdown of large-molecule tissue proteins; 
(d) Increased fluidity of the tissue ground 
substance. 
The increased vascular permeability is considered 
to be the crucial factor in the formation of the 
inflammatory exudate. 
The result is a substantial exudation of plasma-
like fluid into the surrounding tissue interstices 
which produces swelling and oedema. As the exudate 
fluid accumulates, pressure within the tissue in= 
creases and may reduce the rate of blood flow 
resulting in cyanosis of the inflamed area. Sevitt 
(1958) and Miles (1966) state that, in experimentally 
produced acute inflammation, the exudation of fluid 
occurs in two phases. Vinegar et al (1969) consider 
carrageenan-induced rat paw oedema to be a biphasic 
event. (See Section 2,4,3 page 19 Volume lTime Curve). 
(UJ The Cellular Exuda.te 
The increased permeability of the vascular wall 
results not only in proteins passing through, but 
also in a migration of leucocytes into the damaged 
area. In the first stage, mostly polymorphonuclear 
leucocytes migrate (neutrophils). Later monocytes 
migrate in increasing numbers into the area of 
inflammation, become phagocytic and are called 
macrophages. The polymorphonuclear cells provide 
enzymes for the destruction of cellular material. 
Higgs and Youlten (1972) have shown that rabbit 
polymorphonuclear leucocytes produce a Prosta= 
glandin E-like material thought to be prstaglandin Ej. 
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1. 3. 4 
Lymphocytes are considered not to be generally 
involved in acute inflammation. 
CHEMOTAXIS 
Hicks has pointed out that in addition to vasodilation 
and exudation, inflammation creates conditions that are 
conducive to a migration of leucocytes and tissue 
macrophages into the damaged area. Leucotaxine, a mixture 
of kinins, has been associated with chemotaxis. Also the 
components of the complement system have chemotactic 
properties leading to cellular migration into the inflamed 
area. 
THE CHEMICAL MEDIATORS OF INFLAMMATION 
The first agents at the site of a local injury are local 
hormones, which are formed or releas.ed in situ. Whitehouse 
(1974). divides the chemical mediators of inflammation into 
two groups: 
(i) The acids: prostaglandins, heparin, the adenylates 
(cyclic AMP, ADP) and lysolecithins. 
(ii) The bases: histamine, serotonin, the kinins, the 
catecholamines. 
Walter and Israel listed eight groups of substances which 
act as chemical mediators: 
(i) Amines 
(a) his tamine 
(b) 5-hydroxytryptamine (5-HT) 
(ii) The kinins 
(iii) Kinin-forming enzymes 
(a) kallikrein 
(b) the globulin permeability factor 
(c) plasmin 
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(iv) Biologically active products of the complement 
system. 
(v) Biologically active components of polymorpho= 
nuclear cells. 
(vi) Prostaglandins . 
(vii) Nucleic acid and breakdown products. 
(viii) Others, as yet unknown. 
These mediators appear to serve primarily as "alert 
mechanisms" rather than functioning as true effectors 
of tissue injury. Their effect is transitory, either 
because of rapid dilution, removal in the lymph or 
inactivation by enzyme systems. 
If, at any stage, the cause of inflammation is eliminated 
and no severe tissue damage is present, the tissue reverts 
rapidly to its previous normal state. If severe damage 
exists, repair mechanisms come into play. 
STAGES IN THE DEVELOPMENT OF INFLAMMATION 
Tissue damage ----------------~)~ Acute inflammation 
Resolution < 
" , 
, 
, 
, 
, 
, 
~ 
Vasodilation 
Exudation 
Cellular infiltration 
Tissue demolition 
" Suppura tion 
Repair <C!<~-------'--­
calcific~ 
.J, 
Granulation, Fibrosis 
.J, 
Chronic inflammation 
Giant cell formation 
From: Hicks, R., "Inflammation and Repair in Damaged Tissue" 
Brit. Pharmacy Journal September 6, 1975. 
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1.3.6 INTRA-OCULAR INFLAMMATION 
The uveal tract, consisting of iris, ciliary body and 
choroid, forms the vascular and muscular coat of the 
eye and as such bears the burden of all intra-ocular 
inflammation. Any of its three components may be 
affected and the neighbouring tissues are always involved 
in the inflammatory response and seldom escape the effect 
of the damage that results. (Trevor-Roper 1962). The 
characteristic changes known to occur when the rabbit eye 
responds to irritation, namely miosis, vasodilation, an 
increase 1n capillary permeability and a sustained rise 
in I.O.P., are thought to result from the release of 
prostaglandin E2 and prostaglandin F20, into the aqueous 
humour. Ambache et al (1965) 
The sequence of events in uveitis is thought to be: 
(Higgs and Youlten, 1972). 
(i) release of prostaglandins into aqueous humour 
from the iris, 
(ii) invasion of leucocytes, in part resulting from 
the leucotactic effects of. the prostaglandins 
present in the aqueous humour, 
(iii) further prostaglandin release from the leucocytes . 
Injection of prostaglandin into rabbit eyes has been shown 
by Waitzman and King (1967) to produce a sustained rise 1n 
intra-ocular pressure. There is also a significant 
incre.ase in the protein content of aqueous humour 
indicating an increase in the permeability of the blood-
aqueous barrier. Anatomically, the blood-aqueous barrier 
consists of: (Trevor-Roper) 
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(i) 
(ii) 
(iii) 
the anterior iris surface; 
the ciliary epithelium; 
the retina overlying the anterior choroidal 
vessels; 
(iv) the capillary walls of the retinal vessels 
in the posterior half of the retina. 
The increase in the protein content of aqueous humour 
and the congested appearance of blood vessels in the 
region of the iris suggested to Waitzman and King that 
both vasodilation and increased capillary permeability 
playa significant role in the response of the I.O . P. 
to prostaglandins in the rabbit eye. 
The similarities between the observed effects of the 
prostaglandin in the eye and those produced by irritation 
and trauma are clear,showing that prostaglandins can 
mimic the effects of acute ocular irritation. (Eakins, 1974) 
The prostaglandins bring about local vasodilation and 
increased permeability resulting in exudation of fluid 
into the aqueous compartment of the eye from the intra-
ocular blood vessels. This breakdown in the blood-aqueous 
barrier results in a sustained rise in intra-ocular pressure. 
(Beitch & Eakins 1969). 
INTRA-OCULAR PRESSURE 
Normal I.O.P. is an expression of the balance between the 
inflow and outflow of aqueous humour and any sustained 
alteration in I.O.P. reflects a change in one or both of 
these parameters. The aqueous humour is driven out of 
the anterior chamber largely by hydrostatic pressure, and 
its principal outlet being through the spongy mass of 
trabecular tissue in the angle of the anterior chamber and 
into the circular canal of Schlemm. 
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1.3.8 
Ant.,.; or chamber ,Irido-comeal angle 
, 
FIG.2. 
, 
of Scnlemm 
Structures involved i n the formation and 
drainage of aqueous humour. The arrows 
indicate the circulatory pathway taken 
by the aqueous humour. 
In animals other than primates, there is no canal of 
Schlemm (although aqueous veins are sometimes found) 
and the aqueous humour drains directly into a diffuse 
meshwork of veins in the ciliary plexus and thence 
through the sclera into the episcleral plexis (Trevor-
Roper 1962). . 
PHYSIOLOGICAL VARIATIONS IN I . O.P. 
Variations can occur throughout the day depending on 
factors such as: 
(i) changes in secretory activity of the ciliary 
body; 
(ii) respiration and arterial pulse . Pressures 
(iii) 
may fluctuate over a range of 5 mm Hg in the 
course of one inhalation .and 1~2 mm. Hg with. each 
heart-beat; 
the time of day - on waking in the morning, the 
I.O.P. can be 3-4 mm Hg greater than at 6 p . m. 
in the evening; 
(iv) dilation of the pupil - This may cause an 
increase in I.O.P . (Trevor-Roper 1962) . 
The above possible physiological variations were ef f ective ly 
countered in the experimental work in the following manner : 
1 1 
(i) a number of I.O.P. readings were taken on 
each rabbit and a reproduc ib le reading 
established to ensure that respiration and 
the arterial pulse were not causing a 
fluctuation of pressure; 
(ii) the time of day used for experimental work 
was standardised, i.e. the experiments were 
performed in the morning; 
(iii) the rabbits were anaesthetized before the 
I.O.P. readings were taken. 
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CHAPTER 2 
2.1 REVIEW OF METHODS FOR THE DETECTION AND EVALUATION 
OF NEW ACIDIC NON-STEROIDAL ANTI-INFLAMMATORY AGENTS 
In seeking to evaluate the worth of the rabbit eye 
as a test system, it was necessary first to review 
existing methods of evaluation . Methods of assay 
which have achieved popularity have aspects in 
common: 
(i) they are basically simple to perform; 
(ii) they are economical; 
(iii) they can be used to select drugs known to 
afford some benefit in the clinical 
management of rheumatoid disease (Swingle 
1974). 
2.2 SCREENING PROCEDURES 
2.2.1 
Screening procedures can be grouped into four 
categories of assays according to the criterion 
for activity. 
METHOD (1) 
INTERFERENCE with the manifestation of one of the 
cardinal signs of inflammation, e .g. 
(i) Inhibition of swelling . (This parameter is 
used in the classical ra t-paw-oedema method 
of assay) . 
(ii) Inhibition of heat. 
(iii) Inhibi tion of redness . 
(iv) Inhibition of pain. 
(v) Inhibition of loss of function . 
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2.2.2 
2.2.3 
METHOD (2) 
MODIFICATION of one of the events occurring during 
the inflammatory process . 
(i) Inhibition of inflammatory exudation. (This 
parameter is used in the rabbit-eye test 
system). 
(ii) Inhibition of inflammatory isolation. (The 
isolation of an acutely inflamed area is aided 
by the precipitation of fibrin which obstructs 
lymphatic and microvascular flow. Early 
isolation of the area is thought to be desir= 
able because it allows time for phagocytic 
cells to assemble at the site of inflammation). 
(Menkin 1940). 
(iii) Inhibition of inflammatory granulation. 
METHOD (3) 
POSSESSION of a property that has been associated with 
a class of drugs known to be anti-inflammatory. The 
property may be used as a basis for detecting a class 
of anti-inflammatory compounds . Many of these assay 
methods for the acidic non-steroidal anti-inflammatory 
drugs are conducted in vitro and rely on some type of 
interaction of the drug with protein. 
(i) Properties of non-steroidal anti-inflammatory 
drugs. They are: 
(a) the uncoupling of oxidative phosphorylation; 
(b) the protection of protein in solution from 
being denatured by heat; 
(c) the stabilization of erythrocytes and 
inhibition of heat-induced haemolysis 
of canine erythrocytes; 
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2.2.4 
(d) the acceleration of the sulphydryl 
exchange reaction; 
(e) the stabilization of lysosomes (reports 
on this action of non-steroidal anti-
inflammatory drugs have been conflicting 
(Hichens 1974); 
(f) the promotion of dissolution of fibrin 
clots; 
(g) the inhibition of platelet aggregation; 
(h) the promotion of excretion of uric acid. 
(ii) Properties of steroidal anti-inflammatory drugs . 
They are: 
(a) the ability to cause a reduction in weight 
of the lymphoid tissues of rodents; 
(b) the ability to inhibit replication of cells 
derived from connective tissue using cell 
culture techniques. 
METHOD (4) 
MODIFICATION of syndromes purported to be animal systems 
used as models for human rheumatoid diseases. 
(i) Modification of experimental arthritis; 
(ii) Modification of experimental gout; 
(iii) Modification of spontaneous disease. 
2.3 AN "IDEAL" SCREENING PROGRAMME 
Even though drugs such as aspirin, cortisone and 
phenylbutazone and gold preparations were discovered 
without the use of a screening programme, successful 
programmes have been designed. 
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2.3.1 
2.3.2 
2.3.3 
2.3.4 
ACUTE INFLAMMATORY MODELS 
(i) Rat-paw oedema method; 
(ii) Ultraviolet-light-induced erythema of guinea-pig 
skin. This represents a second model of acute 
inflammation in a second species. 
CHRONIC-INFLAMMATORY MODELS 
(i) . Evaluation of the effect of the compound on a 
chronic inflammatory condition, e.g. adjuvant-
induced arthritis of the rat; 
(ii) Effect of the compound on the proliferative 
phase of an inflammatory response, e.g. the 
cotton-pellet-induced granuloma in rats . 
ASSESSMENT OF RELEVANT ANCILLARY ACTIVITIES 
An assessment of the analgesic, antipyretic and 
uricosuric ability of the compound is made . 
ESSENTIAL FEATURES OF A TEST SYSTEM 
Whitehouse (1974) suggested the following as being 
essential features of a test system. 
(i) It should be relevant to human disease; 
(ii) It should be adequate for the type of compound 
to be tested; 
(iii) It should permit clear interpretation; 
(iv) It should avoid biological complication, i.e. 
avoid the need to use animals with an unusual 
pattern of drug metabolism; 
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2.4.1 
2.4.2 
(v) It should be practical, i.e. 
(a) require modest skills and facilities, 
(b) not need prolonged induction time 
(with reference to studies involving 
disabling joint conditions), 
(c) allow economical use of the compound 
being evaluated. 
THE TWO ASSAY PROCEDURES USED IN THIS STUDY 
THE RAT-PAW-OEDEMA METHOD 
Swingle (1974) has stated that probably the best single 
method to evaluate a new drug substance for anti-
inflammatory activity is the rat-paw-oedema method of 
assay. Di-Rosa & Willoughby (1971) suggest that, 
because the standard non-steroidal drugs inhibit 
leucocyte emigration and the "prostaglandin phase" 
of oedema induced by carrageenan injection, this 
assay can be successfully used to search for effective 
anti-inflammatory compounds. This classical method 
of assay, to which the discovery of indomethacin is 
attributed, was therefore chosen for comparison with 
the rabbit-eye test system. 
METHODOLOGY 
The assay as originally described by Winter, Risley and 
Nuss (1962), and as conducted in this study, was carried 
out as follows: 
(i) the drug to be administered was injected 
intraperitoneally at -60 minutes into Wistar 
rats of either sex; 
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2.4.3 
(ii) at zero time, 0,05 cm3 of a 1% suspension 
of carrageenan was injected into the plantar 
tissue of one hind paw of the Wistar rat, 
and the size of the paw determined at this 
time; 
(iii) at hourly intervals for the next three hours 
RESULTS 
after the injection of carrageenan suspension, 
the magnitude of swelling was determined by 
the method of volume displacement of the hind 
paw. 
The findings were expressed as % inhibition of the 
oedema. 
% inhibition = 100~ _ Vt] Vc 
where Vt and Vc are increases in the volume of the 
carrageenan-injected paws of the drug-treated and 
control groups respectively. Winder et al (1957) 
have pointed out that there is no apparent right 
or left "footedness" in rats and that paw volume 
(non-oedematous) to body-weight ratio is constant 
among rats. Arrigoni-Martelli & Conti (1964) found 
that the strain, the sex and the body weight of the 
rats are unimportant variables in the assay. Vinegar 
et al (1969) showed that it is the second phase of the 
oedematous respon~e, occurring after injection of 
carrageenan, that is sensitive to most anti-inflammatory 
drugs. This second-phase inhibition by ANSA! compounds 
was also noticed by this investigator and was the phase 
used to measure the percentage inhibition of oedema 
occurring. The existence of two phases of swelling 
probably explains the failure of standard anti-
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FIG.3. Volume-time curve of developing oedema in 
rats injected in the right footpad with 
0,50 mg of carrageenan (Vinegar et al 1969) 
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2.5 DISADVANTAGES OF THE RAT-PAW METHOD OF OEDEMA 
(i) Spector & Willoughby (1968) have pointed out 
that the rat hind paw method suffers from 
certain disadvantages as a test system due to 
the excessive concentration of serotonin which 
may be released and give an erroneous impression 
of the importance of these amines in inflammation. 
(ii) It has been shown by Doherty & Robinson (1975) 
that the early phase of the reaction resulting 
from an injection of carrageenan is due to the 
trauma of the injection process, since it is 
seen also after injection of the saline alone. 
The early phase of the reaction is independent 
of the quantity of carrageenan injected and is 
not seen following intrapleural injection. 
2.6 THE RABBIT-EYE-TEST SYSTEM AS A METHOD OF ASSAY 
It is well established that certain chemical and 
mechanical injuries to the blood-aqueous barrier are 
frequently followed by the formation of a protein rich 
aqueous humour and an increase in intra-ocular pressure. 
It seems likely that, in both cases, the rate of aqueous 
formation is increased and that capillaries of the 
anterior uvea and of the ciliary epithelium become more 
permeable to protein. 
The inhibition of the acute inflammatory response Ln the 
eye of the rabbit, by ANSAI compounds caused by 
instillation of the prostaglandin precursor, arachidonic 
acid (sodium salt), was regarded as being the result of 
a modification of ONE of the events occurring during the 
inflammatory process. 
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2.6.2 
2. 6.3 
METHOD 
The method consisted of: 
(i) measuring the resting I.O.P. of anaesthetized 
albino rabbits, one eye of the rabbit being 
used; 
(ii) instilling sodium arachidonate, which, when 
converted to PGEz, produces vasodilation, 
increased vascular permeability and cellular 
migration; 
(iii) measuring the I.O.P . at 15, 30 and 60 minutes 
after the instillation of sodium arachidonate; 
(iv) aspirating the eye three hours after inflammation 
was induced, approximately 0,2 cm3 being 
aspirated; 
(v) determining the protein content in the aspirated 
aqueous humour of the drug treated rabbits and the 
control rabbits. 
RESULTS 
The findings were expressed as % inhibition in the 
elevation of I.O.P. 
% inhibition of I.O.P. = 100 [1 - ~~] 
where Pt and Pc are increases in the I.O.P. of the 
drug treated and control groups of rabbits 
respectively. 
AQUEOUS PROTEIN 
A relative comparison was made of the concentration 
of protein present in the aqueous humour of the test 
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rabbits and that of the protein concentration in 
the aqueous humour of the control rabbits. 
The effectiveness of the ANSA! compound evaluated 
in this test system is directly proportional to the 
ability of the compound to inhibit elevation of both 
the intra-ocular pressure and the aqueous humour 
protein content. 
2.7 S~Y 
Current methods of evaluating non-steroidal anti-
inflammatory drugs have been scrutinised and four 
categories of assays presented. 'An "ideal" 
screening programme, as suggested by Swingle, has 
been presented. 
The assay procedures used in this study, viz. the 
rat-paw-oedema method and the rabbit eye method 
have been described. 
22 
CHAPTER 3 
3.1 INFLAMMATORY AGENTS 
3.2 CARRAGEENAN AS AN INFLAMMAGEN 
Carrageenan is a mixture of polysaccharides composed 
of sulphated galactose units. It is derived from 
Irish sea moss. (Chondrus crispus). (Smith et al 
1955). Its use as an oedemogen was introduced by 
Winter et al (1962) who, after testing a variety of 
oedema-producing materials, concluded that it was the 
phlogistic agent of choice for testing anti-inflammatory 
drugs. 
Not all samples of carrageenan are equally effective 
in eliciting an inflammatory response. Effective 
preparations contain A-type galactan (McCandless, 1962) 
(McCandless et al 1964). A certain structural 
integrity of the polysaccharide is essential for 
oedemogenic activity and a degree of heat denaturation 
sufficient to cause the release of esterified sulphuric 
acid from the substance, results in a partial loss of 
activity. (Vinegar et al 1969). 
It would appear that there are distinct phases in the 
development of carrageenan-induced oedema. 
The initial phase occurring during the first hour is 
due to the release of histamine and 5-hydroxytryptamine. 
Thereafter, an increased vascular permeability is 
maintained up to 2! hours by kinin release. During the 
following 3! hours the mediator appears to be one of 
the prostaglandins, which gives rise to a phase of 
accelerated swelling. This prostaglandin-mediated 
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phase appears to be closely associated with a 
migration of leucocytes into the inflamed area. 
(Di-Rosa & Willoughby 1971). All the mediators 
involved appear to be dependent upon an intact 
complement system for activation and release. 
(Giroud & Willoughby 1970). Carrageenan 
activates plasmin (Serafini, Cessi & Cessi 1963) 
as well as the Hageman factor . (Schwartz & Keller= 
meyer 1969). In addition, carrageenan is also able 
to release a kinin-like substance from plasma heated 
at 56°C for three hours. (Di-Rosa & Sorrentino 1968) . 
The apparent importance of leucocyte exudation for a 
full development of an oedema induced by carrageenan 
was recognized by Vinegar et al (1971) and van Arman 
et al (1971). 
These investigators were able to correlate with the 
amount of oedema present, either the number of PMN's 
that emigrated into the carrageenan injected paw or 
the peripheral-leucocyte count. Di Rosa & Willoughby 
have suggested that an inter-relationship exists 
between leucocyte emigration and prostaglandin 
activation in the latter phase of carrageenan-induced 
oedema and postulate that the predictive value of the 
assay resides in the involvement of leucocytes in the 
response. Swingle (1974) states that both mononuclear 
and polymorphonuclear cells are involved in the acute-
inflammatory response to the injection of carrageenan. 
Garrattini et al (1965) compared a number of oedemas 
of the rat paw and concluded that the response induced 
by carrageenan was least affected by non-specific 
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influences, v~z., ambient temperature, humidity, 
diuresis, drug-induced hypothermia or adrenalec tomy. 
Swingle supports the view that the carrageenan test 
has proved to be a reliable method f or detecting 
anti-inflammatory substances while Wiseman (1974) 
points out that the po t ency ratios determined in the 
carrageenan-induced rat- paw-oedema test, beats rank 
order correlation to clinical doses of the anti-
inflammatory drugs examined. 
3.3 ARACHIDONIC ACID AS AN INFLAMMAGEN 
3.3.1 
To induce an inflammatory response in the eye of the 
rabbit, a one-percent solution of arachidonic a c id, 
in the sodium salt, was used. Arachidonic acid is 
the most abundant precursor fatty acid of prosta= 
glandins found in the body of mammals giving rise to 
prostaglandin E2 (PGE2), and prostaglandin F~(PGF2) ' 
HISTORY 
The name "prostaglandin" was introduced by von Euler 
in 1935 to describe vasodepressor-smooth-muscle-
stimulating substances in human semen and in semen 
and vesicular glands of animals . The belief at the 
time that these substances were secreted by the 
prostate gave rise to the name of "prostaglandin" . 
It serves as the generic name for a family of closely 
related lipids whose basic structure, prostanoic acid, 
was first hypothesized by Bergstrom et al (1963) . 
More than a dozen compounds have been recognized as 
members of the principal classes of prostaglandins. 
The principal, naturally occurring prostaglandins are 
classified according to the functional groups attached 
to . the five-membered ring of prostanoic acid. 
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More than a dozen compounds have been recognized as 
members of the principal classes of prostaglandins. 
The principal, naturally occurring prostaglandins are 
classified according to the functional groups attached 
to the five-membered ring of prostanoic acid . 
H 
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Prostanoic acid 
(J6bb6 
• • OH OH 
E F A c B 
The letter designations E and Fare g1ven to prosta= 
glandins possessing a ketonic group and an hydroxyl 
group at C-9, respectively. Both prostaglandin E 
(PGE) and prostaglandin F (PGF) possess a hydroxyl 
group at C-ll as well . For biosynthetic reasons 
the E and F prostaglandins are considered to be 
"parent II prostaglandins. Numerical subscripts, 
e.g. PGEl, indicate the number of double bonds con= 
tained in the aliphatic chain segment of the prosta= 
glandins. The "ex" and "61! subscripts for the F-
prostaglandins designate whether the hydroxyl group 
at C-9 is on the same side of the molecule as the 
aliphatic side chain containing the carboxylic acid 
group, or if it is on the opposite side . The 
naturally occurring F prostaglandins all have the ",," 
configuration, e.g. PGF2'" 
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3.3.2 BIOSYNTHESIS 
Prostaglandins are biosynthesized from poly-unsaturated 
essential fatty acids by a series of complex reactions. 
The current understanding of the details of prostaglandin 
synthesis is based on work done by Klenberg and Samuelsson 
(1965), and Hamberg and Samuelsson(1967) . 
The basic substrate requirements for the enzyme system of 
prostaglandin synthesis are 20-carbon fatty acids with 
mUltiple sites of unsaturation, molecular oxygen, and co-
factors that can act as reducing agents . 
PC"'_/. 
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3.3.3 
Evidence for this pathway was recently presented by 
Hamberg & Samuelson (1973) by the isolation of an 
internal hydroperoxide of arachidonic acid. Phospholi= 
pase activity is believed to be a rate-limiting factor 
in the control of prostaglandin formation. 
MECHANISM OF ACTION OF PROSTAGLANDINS 
Prostaglandins are present in virtually all tissues of 
the body and they have been shown to produce a wide 
variety of responses. They influence intracellular 
responses to many hormones, local blood flow and ion 
movements across membranes and thus, as Russell et al 
(1975) points out, it is difficult to attribute their 
actions to one mechanism. 
General support is given to the concept that E & F 
prostaglandins exert their affects ·by acting locally 
within a tissue or organ after an appropriate stimulus 
to that organ. It is noted that in the inflammatory 
response in the carrageenan-injected rat paw, the 
activation and release of mediators involved, including 
prostaglandin, appear to be dependent upon the complement 
system to trigger it off. Prostaglandins act intra= 
cellularly and Steinberg et al (1964) and Kuehl (1974) 
have studied the interaction of prostaglandins with the 
cyclic-AMP system, and shown that there is a possible 
relationship between the two, as PGEI was shown to block 
the action of lipolytic agents (which act by increasing 
concentrations of cyclic-AMP) in fat cells. 
Another mechanism of action involves the autonomic nervous 
system. Autonomic-nerve stimulation releases endogenous 
prostaglandins in amounts sufficient to exert an inhibitory 
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act i on on t r ansmi t t e r release a t nerve end i ngs . 
(Russell et all The observation that prostaglandin 
biosynthesis can be virtually abo lished by drugs, such 
as aspirin or indon'ethac.in in non-lethal doses, might 
suggest that, whatever the role of prostaglandins, their 
formation cannot be essential for the continued existence 
of the organism. 
THE ROLE OF PROSTAGLANDINS IN OCULAR INFLAMMATION 
There is evidence to suggest that prostaglandins are 
involved in acute ocul ar inflammation . (Ambache e t al 
1965) (Christ & van Dorp 1972). Eakins (1974 ) has 
shown similarities between the observed effects of 
prostaglandins on the eye, and those produced by 
irri tation and trauma, indicating that prostaglandins 
can reproduce the effects of acute ocular irri t ation. 
The use of the prostaglandin precursor arachidonic 
ac id , resulted i n an ocular r esponse in t he rabbit which 
can most likely be attributed to the presence of prosta= 
glandin in the eye . Bhattachejee & Eakins (1975) found 
that PG-like activity (16 + 7 ~g/cm3) could be detected 
in thE aqu~ous humour, thirty minutes after instillation 
of sodium arachidonate. They also point out that, 
although elevated levels of prostaglandin- like activity 
were found in the aqueous humour following topical 
app lication of sodium arachidona te, i t was not clear 
whether the conversion occurred external ly in the 
conjunctiva, with the r esulting prostaglandins passing 
into the aqueous, or internally in the iris/ciliary body, 
since both of these tissues are able to convert arachidonic 
acid to prostaglandins. 
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Beitch & Eakins (1969) found that prostaglandins 
could produce many of the signs of ocular inflammation, 
including vasodilation, increased vascular permeability 
and a raised I.O.P. They suggest that local ocular 
vasodilation and increased vascular permeability were 
important factors in raising the I.O.P . 
Beitch & Eakins also observed that intracameral 
injections of as little as 10 ng of PGE and PGF 
resulted in a significant increase in the protein 
content of the aqueous humour, a phenomenon indicat= 
ing an increase in the permeability of the blood-
aqueous barrier. They found good correlation between 
the concentration of protein in the aqueous humour and 
the sustained increase in I.O.P . produced by either 
prostaglandin. These findings on the protein content 
of aqueous humour, together with the congested appearance 
of blood vessels in the region of the iris, suggest that 
both vasodilation and increased capillary permeability 
playa significant role in the response of I.O.P. to 
prostaglandins in the rabbit. 
In the sequence of events in developing uveitis, 
prostaglandins were implicated as follows: 
(i) prostaglandins were released into the aqueous 
humour from the iris; 
(ii) an invasion of leucocytes occurred and resulted 
possibly from the leucotatic effect of the 
prostaglandins present in the aqueous humour; 
(iii) a further prostaglandin release from the 
leucocytes occurred, Higgs and Youlten (1972) 
and Vogt (1974) 
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3.3 . 5 
3.3.6 
It has been stated by Cochrane & Janoff (1974) that 
the invasion of an inflamed area by polymorphonuclear 
and mononuclear cells is an important factor in 
prolonging inflammation. As soon as leucocytes have 
accumulated and deteriorated, a vicious circle may 
develop due to the release of lysosomal enzymes, which 
can degrade macromolecules and liberate mediators 
including prostaglandins as well as chemotactic factors. 
Kaley and Weiner (1971) support the view that prosta= 
glandins are chemotactically active and may act as 
mediators in leucocyte migration. However, McCall and 
Youlten (1973) found that only PGEI possesses chemotactic 
properties for the polymorphonuclear leucocytes. 
PROSTAGLANDIN EFFECT ON INTRA-OCULAR PRESSURE 
The available evidence suggests that the increased inflow 
of aqueous humour noticed in the rabbit eye after 
prostaglandin formation is related more to permeability 
changes of the blood aqueous barrier than to increased 
secretory activity. Starr (1971) demonstrated that 
prostaglandins could raise intra-ocular pressure in 
rabbits even when given by way of intravenous injec tion. 
Masuda (1972) showed that topical application of PGEI to 
the rabbit eye increased the inflow, but not the outflow 
of aqueous humour. The lack of effect of prostaglandins 
on the outflow has also been reported by Chiang & Thomas 
(1972) • 
THE ROLE OF PROSTAGLANDINS IN THE CARRAGEENAN-i:NDUCED 
INFLAMMATORY RESPONSE IN THE RAT PAW 
There is evidence to support the view that prostaglandins 
are involved in the carrageenan-induced inflammatory 
response in the rat paw. 
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Flower et al (1972} and Vane (197l} demonstrated a 
close relationship between inhibition of prostaglandin 
synthetase and the anti-inflammatory action of a number 
of drugs used in rheumatology with indomethacin, a 
prostaglandin synthetase-inhibitor, showing a particularly 
strong action on rat-paw-oedema. 
Di Rosa and Willougby (1971) have implicated prostaglandin-
like substances in carrageenan-induced rat-paw-oedema and 
believe that the second accelerating phase of swelling is 
due to a prostaglandin . This is the phase which 1S 
blocked by acidic non-steroidal anti-inflammatory drugs. 
Willis (1969) found an E type prostaglandin in the rat-paw 
exudate, during this secondary phase of inflammation . 
Smith et al (1974) used a specific prostaglandin 
antagonist, dibenzoxazepine hydrazide (SC 19220), which 
reduced the development of the carrageenan-induced paw 
swelling significantly, a response showing that the 
prostaglandin system is concerned in the development of 
carrageenan-induced paw oedema. 
Results from this present study, 1n which four prosta= 
glandin synthetase inhibitors . were used, showed inhibition 
of the secondary phase of inflammation. These results 
indicate that prostaglandins are involved. The release 
of prostaglandins appear to be closely associated with 
the migration of leucocytes into the inflamed site. 
3.4 SUMMARY 
Carrageenan as a phlogistic agent and its suitability as an 
inflammogen 1n the rat-paw-oedema method of assay, has been_ 
discussed. 
A short review has been given on arachidonic acid, a 
precursor of the prostaglandins, and the history, bio= 
synthesis and mechanism of action of the prostaglandins 
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presented. Russell et al (1975) 
The role of the prostaglandins, with particular 
reference to ocular inflammation, has been reviewed 
with reference to the effect of prostaglandins on 
intra-ocular pressure. 
The carrageenan-induced inflammatory response in the 
rat-paw has been examined, and the possible involve= 
ment of prostaglandins in the secondary phase of swelling, 
has been considered. 
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4.1 
4.1.1 
4.1.2 
CHAPTER 4 
CHEMISTRY OF ACIDIC NON-STEROIDAL ANTI-INFLAMMATORY AGENTS 
DEFINITION 
Scherrer (1974), has defined a classical non-steroidal anti-
inflammatory agent as a compound that is active in the 
carrageenan and adjuvant-arthritis assays; is antipyretic; 
and is active in the ultra-violet-erythema assay. 
definition includes the salicylates and aspirin-like 
compounds. 
RECEPTOR SITE 
This 
A hypothetical receptor outline was proposed by Scherrer 
et al (1964), for classical anti-inflammatory agents. 
Fig.~. The same receptor design is a model for 
prostaglandin synthetase. The reference 
point underlies the N and carbonyl carbon 
respectively, of the fenamic acids and ' 
indomethacin. 
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Two features of the receptor were a cationic si.te and 
a trough to accept a twisted ring. Shen (1965) has 
suggested a similar receptor topography based on the 
analysis of structure-activity relationships and the 
preferred configuration in the indomethacin-compound 
series. 
Fig. 6. The configuration ofindomethacin as proposed to fit a hypothetical antiinflammatory 
receptor (Shen, 1965) . This receptor has the main features indicated in Fig. but with a 
different o rientation for the trough . 
4.1. 3 ACIDIC NON-STEROIDAL ANTI-INFLAMMATORY AGENTS AND 
PREFORMED PROSTAGLANDINS 
Scherrer (1974) has shown that prostaglandin Ez 
closely resembles classical non-steroidal anti-
inflammatory agents as shown: 
Indomethacin 
Fig.J. A possible conformation of PG~ at the prostaglandin synthetase antiinftamatory 
receptor (absolute configuration) compared with indomethacin, a potent inhibitor. 
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Just a acetylcholine and histamine have mUltiple 
receptors, Scherrer proposes that wherever the 
classical anti-inflammatory agents act as potent 
inhibitors of the action of a preformed prostaglandin, 
this action is more likely to occur at a receptor at 
which the prostaglandin has a conformation similar to 
that in Fig.7. Vane (1971) has shown that indomethacin 
tested in vitro inhibited the synthesis of prostaglandins. 
If the inhibition resulted from competition with arach i= 
donie acid for the active site of the enzyme, it could 
explain why the anti-inflammatory substances contain an 
acidic group. 
INHIBITION OF PROSTAGLANDIN SYNTHESIS 
Non-steroidal anti-inflammatory agents have been shown 
to inhibit the biosynthesis of prostaglandins in a 
variety of tissues. (Vane 1971), (Smith and Willis 1971) 
and (Fereira ~ 1971). This action may account for 
their therapeutic activity (Ferreira and Vane 1973). It 
has been suggested by Eakins (1974) that the importance 
o f prostaglandins in certain forms of ocular inflammation 
suggests that drugs that inhibit either the actions or 
synthesis of prostaglandins may prove useful as ocular 
anti-inflammatory agents. Samuelsson et al (1975) state 
that arachidonic acid can be converted to prostaglandin E2 
and prostaglandin F2a. 
Ham et al (1972) have shown that prostaglandin production 
fr om arachidonic acid can be inhibited in vitro by a 
variety of anti-inflammatory agents and Gryglewski (1975) 
reported that non-steroidal anti-inflammatory drugs inhibit 
. microsomal prostaglandin synthetase. Smith and Willis 
(1971) have stated that indomethacin, aspirin and salicylic 
acid, but not hydrocortisone, inhibited the thrombin-induced 
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production of prostaglandin by human platelets. 
Tomlinson et al (1972) recovered the arachidonic acid 
unchanged after inhibition by anti-inflammatory drugs 
utilizing a bull seminal vesicle enzyme system and 
naproxen. It has been postulated by Flower et al (1972) 
that the high level of activity and specificity of many 
acidic non-steroidal anti-inflammatory compounds in 
inhibiting prostaglandin synthetase, could explain the 
mode of action of these agents in vivo . This observation 
has been supported and the ability of the ANSAI agents to 
inhibit prostaglandin synthetase, is thought to underlie 
the therapeutic anti-inflammatory activity of this class 
of drug . Stone et al (1974). 
PROSTAGLANDIN-SYNTHETASE INHIBITORS 
Prostaglandins are believed to be responsible for many of 
the clinical signs in acute anterior uveitis . Therefore, 
substances which antagonize their actions or synthesis, 
should be of value in controlling ocular inflammation. 
Rodger et al (1973). 
Thus, in the rabbit-eye test system, sodium arachidonate 
was instilled into the rabbit eye, prostaglandin formation 
was brought about and an inflammatory response noticed, 
i.e . an increase in intra-ocular pressure and an increase 
in the protein content of aqueous humour resulted. 
The author used fonr prostaglandin-synthetase inhibitors, 
viz., indomethacin,. diclofenac sodium, flufenamic acid and 
sulindac, to inhibit the formation of prostaglandins. 
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4. 1.6 CHEMICAL STRUCTURES OF THE ACIDIC NON~STEROIDAL 
ANTI-INFLAMMATORY COMPOUNDS EVALUATED 
CHSO ~ H2COOH 
~ N HS 
Indomethacin 
~O 
CI 
_I 
F 
Sulindac 
H 
II 
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4.2 INDOMETHACIN (See Structure I) 
Inhibition by the 
ANSAI Drugs 
(Goodman and 
Gilman, 1975) 
Indomethacin, an indole acetic acid derivative, was shown 
by Winter et al (1963) to exhibit prominent anti-inflammatory 
and antipyretic properties in experimental animals . Ham et al 
(1972) have reported that kinetic studies indicate that the 
conversion of arachidonic acid to prostaglandin E2 is 
competitively inhibited by indomethacin. According to 
Ariens E.J., (1971), this means "that a relationship in 
chemical structure may be expected between the natural 
substrate-product and the anti-inflammatory agent". See Fig 
Vane showed that indomethacin, tested in vitro, inhibited 
the synthesis of prostaglandins and Ku et al (1975) states 
that indomethacin acts as a competitive and irreversible 
inhibitor of prostaglandin synthetase . 
40 
Spector and Willoughby (1968) believe that indomethacin 
also interferes with the kinin-forming system. It was 
shown by Ford-Hutchinson et al (1975) that indomethacin 
inhibited the migration of both polymorphonuclear cells 
and mononuclear cells into the exudates of implanted 
sponges . 
4.3 DICLOFENAC SODIUM O-(2,6-DICHLOROANILINO) PHENYLACETIC 
ACID SODIUM SALT (VOLTARENR) (See Structure IV) 
The active substance contained in Voltaren is the sodium 
salt of N-phenylamino-phenylacetic acid (Krupp et al 1975). 
It is equal in oedema inhibiting ability, to indomethacin 
in the carrageenan-oedema assay and such correlation has 
also been shown by use of the rabbit-eye-test system. 
Diclofenac sodium is also reported to have similar activity 
to indomethacin in adjuvant arthritis. Krupp et al (1972). 
Piper and Vane (1969) and Moncada et al (1973) state t hat 
the pharmacological effects of d iclofenac sodium in their 
work, were consistent with a mechanism of action involving 
inhibition of prostaglandin synthesis, the mechanism that 
appears to explain the biological effects of non-steroidal 
anti-inflammatory drugs. This concept is supported by Ku 
et al (1975), who have shown that diclofenac sodium in low 
concentration inhibited prostaglandin synthetase, markedly 
interferring with the synthesis of prostaglandin E2 from 
arachidonic acid . This effect on the b i osynthesis of 
prostaglandins, coupled with the ability of diclofenac 
to accumulate at sites of inflammation (Fruh et al 1975), 
is considered a fac t or contributing to the high level of 
potency of diclofenac . 
The low Kl (inhibition constant) of diclofenac sodium is an 
indication that this substance is among the most potent 
compounds within the non-steroidal anti-inflammatory drugs. 
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Ku et al (1975). Results obtained with diclofenac sodium 
in the rabbit-eye-test system support this observation. 
Diclofenac sodium was administered in doses of one mg per Kg, 
the results comparing extremely well with those obtained with 
drugs administered i n far higher doses. 
4.4 FLUFENAMIC ACID (See Structure III) 
The N-arylanthrani lic acids, used in man have been given 
the generic name of "fenamic acids ll • They were first 
described as an anti-inflammatory agent in a series of 
reports from Parke-Davis by ·Winder et al (1963). 
The mechanism of action of flufenamic acid is believed to 
be that of an inhibition of prostaglandin synthesis. 
Inhibition has been shown to occur in in vitro experiments 
in which meclofenamic acid is active in inhibiting prosta= 
glandin synthetase. (Flower et al 1972). Meclofenamic 
acid was found to have an EDSO value of 0,03 ~g/cm3 to 
inhibit prostaglandin synthetase. The value for flufenamic 
acid is 0,7 ~g/cm3 . (Scherrer 1974). 
The ability of flufenamic acid to counter the effects of the 
prostaglandin-induced inflammatory response in the rabbit-
eye-test system compared favourably with the compounds 
evaluated. This compound showed a marked effect in 
inhibiting increase of both the intra-ocular pressure and 
of the aqueous protein level at a dose of 10 mg per kg . 
4.5 SULINDAC, MSD (See Structure. II) 
Sulindac, like indomethacin, is an indene-type compound, 
with a structure similar to indomethacin 
Sulindac inhibits prostaglandin synthesis and the action 
thus resembles that of indomethacin. The ability of 
Sulindac to inhibit the prostaglandin-induced inflammatory 
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response in the rabbit-eye-test system, was noticed. 
4.6 S~Y 
A classical non-steroidal anti-inflammatory agent has 
been defined and a hypothetical receptor proposed 
(Scherrer et al 1964) (Shen 1965). A possible 
conformation of prostaglandin E2 has been compared with 
that of indomethacin. The inhibition of prostaglandin 
synthesis has been studied and four prostaglandin 
synthetase inhibitors were discussed . The ANSAl com= 
pounds studied were indomethacin , diclofenac sodium, 
flufenamic acid and sulindac. 
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CHAPTER 5 
5.1 EXPERIMENTATION: AIMS & PRELIMINARY CONSIDERATIONS 
In order to determine the inhibition of the increase 
of intra-ocular pressure and the protein content of 
the aqueous humour of the eye, it was necessary to 
perfect techniques for: 
(i) measuring the intra- ocular pressure 
(I.O . P.) of the rabbit eye; 
(ii) aspirating the eye of the anaesthetized 
rabbit. 
These techniques initially presented more problems 
than the rat paw oedema method of assay where Winter 
Risley and Nuss (1962), and subsequently many other 
investigators, have published widely. 
5 . 2 INF~TORY RESPONSE 
Various methods of producing an inflammatory response 
were studied and turpentine oil was used to significantly 
~ncrease the I.O .P. as well as the rat paw volume. 
However, it was discarded as a suitable screening 
substance because of its low sensitivity and specificity. 
(Swingle 1974). 
Instead, the prostaglandin precursor, arachidonic acid, 
was chosen as the agent to induce the inflammatory 
response in the rabbit eye and carrageenan was chosen 
as a suitable phlogistic agent to induce acute 
inflammation in the rat paw. 
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5.3 MEASUREMENT OF INTRA-OCULAR PRESSURE 
At first measurement of I . O. P. was recorded by means 
of a hand-operated Schiotz tonometer , but later by 
means of the Mackay-Marg tonometer, which supplies 
a print-out record of the pressure recorded. 
5.4 PROTEIN DETERMINATION 
The modified Biuret method was used in initial 
determinations, but was found not to be sensitive 
enough. However, the turbidimetric me thod of 
protein determinations, used in e.S.F. investigations, 
proved to be suitable. 
5.5 MEASUREMENT OF RAT PAW VOLUME 
A method adopted by Winter et al (1962) for measurement 
of paw volume makes use of a 25 rom diameter glass 
cylinder containing mercury and connected via a Statham 
pressure transducer to a galvanome t er. Immersion of 
an object of 1 ml volume into the mercury produced a 
deflection of 35 scale divisions on the galvanometer. 
Hall and Hallet (1975) have made use of a method based 
on Archimedes' principle . The experimental set-up 
provides a relatively large surface area of mercury 
and thus provides ease of access as well as the 
possibility of accurate alignment of the paw. This 
method, which is described under 5,19,2 was adopted 
by this investigator. 
5.6 METHOD OF ANAESTHETIZATION 
Initially, anaesthesia was induced by inserting a small 
vein set into the main drainage vein of the ear and then 
anaesthesia maintained at a uniform level by administration 
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of the anaesthetic as required . This approach 
proved to be a time-consuming operation and sub-
cutaneous administration of the anaesthetic was 
therefore adopted. (Straughan, 1975) 
5.7 EXPERIMENTAL ANIMALS 
Albino rabbits, with a body mass of two to three 
kg, were found to be suitable and were used in the 
rabbit-eye-test system. It was noticed by the writer 
that younger, lighter rabbits tended to present 
difficulties for the measuring of the I.O . P., for 
their eyes are not as well developed as older, more 
mature rabbits. This difficulty was especially 
prominent when oedema of the eye developed as a 
result of the instillation of sodium arachidonate . 
Rabbits of both sexes were used, as the sex did not 
appear to affect the reponse. 
Wistar rats were also used, having an average mass of 
200 g. Weight or sex did not appear to affect the 
response. (Arrigoni-Martelli, and Conti, 1964). 
5.8 EXPERIMENTAL - MATERIALS AND METHOD 
5.8.1 RABBIT EYE: THE TEST SYSTEM 
Albino rabbits of either sex, weighing approximately 
2 to 3 kg, were used; eight rabbits for each 
determination. This was the maximum number that it 
was possible to manipulate at once. The drug used 
to evaluate the rabbit-eye-test system was injected 
intravenously into fQur rabbits into the marginal 
vein of the ear at -60 minute time. At -30 minutes 
the drug was instilled into the rabbits' left eye. 
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The control rabbits received sterile normal saline 
by the same route. A dose of 2,5 ml of AlfathesinR 
per kg, injected subcutaneously, induced a level of 
anaesthesia sufficient to allow measurement of the 
intra-ocular pressure. This light anaesthesia 
persisted usually for more than an hour after which 
time anaesthesia could be maintained by a further 
subcutaneous injection of two to three ml of 
Alfathesin~ The rabbits tolerated the anaesthetic 
very well provided the anaesthetic was administered 
at a slow rate. Pentobarbitone was also tried as 
an anaesthetic , but the response of the rabbits was 
variable and a number of animals were lost. 
Once a uniform level of anaesthesia had been attained, 
the resting intra-ocular pressure was measured. The 
probe which converted the I.O.P. into an electrical 
signal, was brought into contact with the cornea. 
The ensuing electrical signal was amplified and 
recorded by means of a hot stylus onto heat-sensitive 
tonopaper. 
Once the resting I.O.P. had been r ecorded, sodium 
arachidonate solution was instilled into the left 
eye at time 0, and the intra-ocular pressure was 
measured after 15, 30 and 60 minutes. 
5 . 8 . 2 ASPIRATION OF THE EYE 
Three hours after inflammation had been induced , the 
anterior chamber of the eye was aspirated by the use 
of a 26 gauge needle. 
as follows: 
The operation was carried out 
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5.9 
5.9.1 
Alfathesin was administered intravenously to re-
anaesthetize the rabbit, and once a suitable depth 
of anaesthesia had been attained, the eye was 
immobilized by means of opthalmic forceps . (Seepage 92, P6). 
The needle was then carefully inserted into the 
anterior chamber of the eye, horizontally to the iris, 
and the aqueous humour removed. (Approximately 0,2 ml 
was obtained from each eye). The aqueous humour from 
the four test animals was pooled and a protein 
determination carried out. The aqueous humour of 
the control eyes was similarly treated. A 0,4% 
solution of oXYbuprocainium was instilled into the 
eye to cause local anaesthesia , but the author found 
that the local anaesthesia produced was insufficient 
to allow aspiration to be carried out and general 
anaesthesia was necessary . 
PREPARATION OF THE MATERIALS 
Sodium arachidonate was obtained from the Sigma 
Chemical Company in ampoules containing 50 mg, and a 
1% aqueous solution was prepared with distilled water. 
The aqueous solution of sodium arachidonate was stored 
in a frozen state and kept its potency for at least 
one week in this form . 100 ~l was instilled into 
the rabbit eye. 
Initially 5% arachidonic acid was dissolved in soya 
bean oil which, due to its anti-oxidant properties, 
was able to keep the arachidonic acid from oxidation. 
(Straughan, 1975). The most effective application 
form of arachidonic acid was as the sodium salt and a 
one-percent solution yielded a reproducible sub-
maximal response. (Bhattacherjee and Eakins, 1975). 
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5.9.2 
5.9.3 
5 . 9.4 
5.9,5 
5 . 10 
Indomethacin (Merck, Sharp and Dohme) , Four mg per kg 
was administered to the test rabbits. The 0,257. 
indomethacin solution was prepared by adding equimolar 
quantities of Na2C03 to an aqueous suspension of 
indomethacin. Using a 25 gauge needle, the solution 
was injected intravenously into the marginal ear ve~n 
through a 0,2 ~m filter (Acrodisc - Gelman) to render 
the solution sterile. 
Flufenamic Acid (Parke-Davis). A 17. solution was 
prepared with triethanolamine as a solubilizer. 10 mg 
per kg body weight was administered intravenously. 
Diclofenac Sodium (Ciba-Geigy). A 0,27. aqueous solution 
of sodium diclofenac was prepared and administered intra= 
venously. 1 mg per kg body weight was administered. 
Sulindac (Merck, Sharp and Dohme). The dose administered 
was 3 mg per kg body weight, An aqueous 0,27. solution 
was prepared by the addition of an equimolar quantity of 
Na2C03' 3 mg per kg was administered intravenously . 
The above four drug solutions were also used for topical 
administration into the rabbit eye. The drug being 
evaluated was instilled 30 minutes before instillation 
of the sodium arachidonate. 
THE ANAESTHETIC 
AlfathesinR which is well tolerated in cats, also produced 
a level of anaesthesia in the rabbit suitable for allowing 
I,O.P, measurements to be taken and for the eye to be 
aspirated. 
AlfathesinR ~s a steroid anaesthetic for intravenous use 
with both induction and recovery from anaesthesia occurring 
rapidly. The active ingredients of this preparation are 
two pregnanedione derivatives, alphaxalone (3u-hydroxy-5u-
pregnane-ll,20 dione) and alphadolone acetate (21-acetoxy 
4~ 
5.11 
5.12 
3u-hydroxy-5u-pregnane-II,20 dione). The latter has 
about one half the anaesthetic activity of the former 
and has been included to improve the solubility of 
alphaxalone. AlfathesinR has a therapeutic index 
of about 30 in mlce as 
thiopentone sodium. 
compared to 6,9 in the 
h . R Each ml of Alfat eSln 
case of 
contains 
9 mg of alphaxalone and 3 mg of alphado l one acetate . 
THE MACKAY-MARG TONOMETER 
The tonometer consists of two basic parts: the probe, 
which converts the intra-ocular pr essure into an 
electrical signal, and the amplifier- recorder unit, 
which aplifies and records the output signal from the 
probe . The probe shell is made of stainless steel and 
at the centre of the tip of the nose-piece (which is 
pressed against the cornea through a rubber membrane 
during measurement) cons i sts of a ceramic actuating 
rod, whose sub~icroscopic movements are detected and 
amplified to produce a tonogram. (See page 92 P3) . 
Measurements are derived from intra-ocular pressure 
acting through the flattened cornea against the actuating 
rod causing minute movements . 
AMPLIFIER~RECORDER 
(Se.e Page 92 P5). The. amplifier recorder supplies a very 
weak high-frequency alternating current to the transducer 
in the probe. This current , modified according to the 
pressure on the ceramic actuating rod, is amplified several 
hundred times in the probe . It then returns to the amplifier 
for further amplification . The recorder now converts this 
amplified current to a permanent record by means of a hot 
stylus on a heat-sensitive chart paper. 
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5.13 CALIBRATION OF TONOMETER 
5.14 
It is necessary to check the calibration of the instrument 
before taking I.O.P . readings . This is done by setting 
the instrument at x2; each small division on the tonopaper 
then is equivalent to 2 mm Hg pressure on the probe face. 
The probe is then held vertically between thumb and fore= 
finger with the tip of the probe pointing upwards. The 
probe cable is held in the other hand and, using it as 
a lever, the probe is inverted smoothly and quickly so 
that the tip is pointing straight down. The thumb and 
forefinger holding the probe act as a pivot. After a 
five-second pause, the probe is pivoted again so that the 
tip points straight up and is held in this position for 
five seconds. Repetition of this procedure produces a 
series of step changes which are compared with the Proper 
Calibration Trace supplied with the tonometer. 
PAPER SPEED 
The paper speed of 5 mm per second was used in recording 
the intra-ocular pressure. A speed of 25 mm per second 
reduces paper consumption, but produces compressed 
tonograms. Economy was sacrificed for clarity. 
5.15 TONOMETER SCALE 
Normally the I.O,P. was recorded at a setting of x2, but 
ln cases where the I.O.P. increased to high levels, the 
x4 setting was used. Each scale division on the tonopaper 
then represented 4 mm Hg. 
5.16 PROBE APPLICATION .(See page 92, P4). 
The probe was brought into contact with the cornea with 
a feather-light tapping motion, the probe having been 
positioned about 2 to 4 mm away from the cornea. The 
motion of touching is done in very short strokes with the 
tip of the probe perpendicular to the middle of the 
corneal surface. 
5] 
5.17 
CORRECT TECHNIQUE 
probe 
cornea 
This procedure ensured that the sensing rod was 
the first portion to touch, a pre-requisite for 
producing a good tonogram. 
ANALYSIS OF THE TONOGRAM 
An ideal tonogram contains seven main components, 
the most important one being the initial inflection, 
which provides the actual measurement of the intra-
ocular pressure. 
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Maximum induced 
pressure point 
Initial Inflection 
Initial Stylus 
Response 
Base LiT;le 
) 
B 
~.d 
Probe withdrawal 
Secondary Inflection 
Secondary Stylus 
Response 
THE SEVEN COMPONENTS OF A TONOGRAM 
Line A shows the amount of induced pressure due to 
flattening of the cornea. This induced pressure 
occurs after the measurement of the intra- ocular 
pressure and is caused by changing the volume of the 
eye by flattening it beyond the area where the pressure 
reading is taken. 
Line B represents the actual measurement of the intra-
ocular pressure . This measurement is not affected by 
the induced pressure change . 
. - - -._ ------._ - -
A TONOGRAM 
(Each division is equivalent to 2mm Hg) 
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5.18 PROTEIN-DETERMINATION PROCEDURE 
A turbidimetric method using Sulphosalicylic acid 
was employed for determining the protein content 
of the aqueous humour. 
5.18.1 METHOD 
0,1 ml of the pooled aqueous humour sample was made 
up to 1 ml with distilled water . 1 ml of a 5% -
sulphosalicylic acid solution was then added and the 
solution allowed to stand for five minutes. 
A Leitz colorimeter fitt ed with a 640 red filter was 
employed to obtain readings and the protein content 
of the aqueous humour was calculated in g per 100 mI . 
5.19 THE RAT PAW OEDEMA METHOD OF ASSAY 
5.19.1 METHOD 
Wistar rats of either sex and weighing approximately 
200 g were used for this assay. The four ANSAI 
compounds used, i.e. indomethacin, diclofenac sodium, 
f1ufenamic acid and su1indac, were solubilized as 
under 5.9 Each drug was injected intraperitoneally 
into the rat one hour (-60 minutes) before injection 
of the carrageenan into the rat paw. 
The dosage used was: Indomethacin 4 mg per 
Flufenamic acid 10 mg per 
Diclofenac sodium 1 mg per 
Sulindac 3 mg per 
The control rats received an intraperitoneal injection 
of sterile normal saline. 
kg 
kg 
kg 
kg 
Thiopentone sodium was used to provide a light anaesthesia 
so as to allow easy handling of the rats. The anaesthetic 
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was administered both to test and control rats thus 
eliminating possible variation in swelling, which 
might have been attributed to the anaesthetic. 
The suggested human dose of thiopentone sodium is 
, 
40 mg per kg. The average mass of the rat was taken 
to be 200 g, and the dose administered was 8 mg. This 
made the rats sufficiently docile for the purposes of 
manipulation. 
The anaesthetic started to take effect after approx.= 
mately ten to fifteen minutes and usually lasted for 
about two hours. 
At zero time, i.e. one hour after administering the 
ANSAI compound, the phlogistic agent, carrageenan, 
was injected into the right hind paw. (See page 92, Pi). 
Carrageenan, an extract of chondrus was prepared as 
a 1% suspension in sterile 0,9% NaC1 water solution. 
A few drops of 95% alcohol were employed as a wetting 
agent to wet and disperse the carrageenan before the 
sterile normal saline was added. Thorough mixing 
was necessary to ensure a uniform suspension. A volume 
of 0,05 ml was injected through a 26-gauge needle into 
the plantar tissue of the right hind paw . Immediately 
thereafter, the volume of the injected foot was measured 
by immersing the foot into the beaker of mercury exactly 
to an ink mark on the skin just beyond the lateral 
malleolus of the hind paw. Swelling of the paw reached 
a peak in 3 - 5 hours, but for routine drug testing, the 
increase in foot volume three hours after the phlogistic 
agent was injected was adopted as the measure of the 
effect. (Winter, Risley and Nuss, 1962) . The increase 
in foot volume between one and three hours after the 
injection of carrageenan was adopted as the measure of 
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the effect by this investigator. 
5.19.2 METHOD OF MEASURING FOOT VOLUME (See page 92, P2). 
The procedure developed by Hall and Hallet (1975) is 
based on Archimedes'principle . A beaker of mercury 
(50 ml beaker containing approximately 35 ml of 
mercury)' is mounted on a two decimal top-loading 
digital balance. (Sauter SM 1000). The increase 
in weight registered by the balance was read after 
insertion of the animals paw into the mercury. The 
weight of the volume of mercury displaced by the swollen 
paw is proportional to the volume of the paw. When 
necessary, it was possible to tare rapidly between 
readings (two operators were necessary). 
The paw volumes were measured hourly for three hours 
after the injection of carrageenan. The data were 
expressed as the percentage inhibition of the oedema 
formation. 
% inhibition = 100 [ 1 - ~~ ] 
where Vt and Vc are the increases in volume of the 
carrageenan-injected paws of the drug-treated and the 
control groups respectively. In this investigation, 
the second-phase volume of the swelling was determined 
by calculating the increase in paw size that occurred 
between hour 1 and hour 3 after the injection of 
carrageenan. The ANSAI compounds were evaluated 
against the response in the second phase of oedema, the 
phase which was blocked by the class of drug used in 
this study. 
Batches of 24 rats appeared to be a suitable working 
arrangement. Eight rats were used as a control and 
eight rats for each drug. A total of 236 readings 
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5 .20 
of paw volumes were taken in the evaluation of the 
four ANSAI compounds used. 
SUMMARY 
(i) A description of the experimental procedures 
used for the determination of the two parameters, 
viz. intra-ocular pressure and the protein 
content of aqueous humour of the eye of the 
anaesthetized albino rabbit , have been given . 
The methods in solubilizing the four ANSAI 
compounds have been discussed. The anaesthetic 
used and the method of producing anaesthesia 
has been explained. The Mackay-Marg tonometer 
has been discussed and the interpretation of a 
tonogram studied. The technique necessary to 
obtain legible tonograms was presented. The 
aspiration of aqueous humour has been described 
and the method of protein determination given. 
(ii) The experimental detail of rat paw oedema method 
of assay has been described. Sedation of the 
rats with thiopentone sodium has been discussed . 
Hall and Hallet's method for measurement of paw 
volume was also presented. 
57 
CHAPTER 6 
RESULTS 
The Student's T Significance Test 
was the method of statistical analysis 
used. 
TABLES 1 - 8 
GRAPHS Figures IX - XX 
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Table I 
INHIBITORY EFFECTS OF INDOMETHACIN ON THE ACTION OF TOPICALLY INSTILLED SODIUM ARACHIDONATE 
Intra-ocular pressure recorded Percentage 
at IS, 30 and 60 minute Increase Inhibition of intervals after instillation in 3 Intra-ocular Resting of 1% Sodium Arachidonate Pressure % Aqueous Pressure 2 LO.P. mm Hg Increase Protein 
= 100[1 - ~~1 Pretreatment mIll Hg (xl) 15 min 30 min ~O min (x2) (x2-x l) In LO.P. g % 
CONTROL I 
RABBITS (8) 
Sterile normal 4 
saline 20,62 :!:4,2 55,6 ::!:13, 42,6 :!:7,4 35,62 ::!:5,O 15,0 :!:5,' 72,7% 2, 0 
TEST 
;= 100 [1 - 5, 2J RABBiTS (8) 72,7 
Indomethacin = 92,9% 
4 mg per kg 19,6 :!:3,4 25,S ::!:8,l 27,0 ::!:7,C 20,6 :!:2,4 1,0 ::!:l,' 5,2% 0,4 
I Number of animals used in parenthesis 
2 Pt and Pc are % increases in the I . O.P. of the drug treated and control groups of rabbits respectively . 
3 Pooled samples were used to estimate protein . 
4 Standard deviation. 
(P < 0,005) 
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(P < 0,005) 
INTRAOCULAR PRESSURE READINGS IN EIGHT TEST 
RABBITS PRETREATED WITH INDOMETHACIN 0---0 
AND IN EIGHT CONTROL RABBITS . • 
15 30 60 
Time (minutes) 
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TABLE II 
INHIBITORY EFFECTS OF DICLOFENAC SODIUM ON THE ACTION OF TOPICALLY INSTILLED SODIUM ARACHIDONATE 
I 
Intraocular Pressure recorded Percentage 
at 15,30 and 60 minute Increase Inhibition of intervals after instillation in 3 Intraocular 2 Resting of 1% Sodium Arachidonate Pressure % Aqueous Pressure I.O.P. nnnHg Increase Protein 
= 100 ~ - ~~] Pretreatment mm Hg (Xl) 15 min 30 min 60 min (XV (X2-x l) in I.O . P. g % 
CONTROL I 
RABBITS (4) 
Sterile normal 
_ 4 
saline 18 ,75 :!:3,9 39,5 :!:5,0 39,75 :!:2,9 34,5 :!:7.2 15,75:!:7,5 84% 2,0 
TEST 
= 100 ~ - 8~ RABBITS (4) 
Diclofenac = 90,4% 
Sodium 
1 mg per kg . 21,75 :!:2,9 32,0 :!:7,3 29,75 :!:7,2 23,5 :!:4,1 1,75:!:3,1 8% 1,0 
- -- ---
I Number of animals used in parenthesis 
2 Pt and Pc are % increases in the I.O.P. of the drug treated and control groups of rabbits respectively 
3 Pooled samples were used to estimate protein 
4 Standard deviation. 
(P < 0,01) 
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FIG.10. 
(P < 0 , 01) 
INTRAOCULAR PRESSURE READINGS IN FOUR TEST 
RABBITS PRETREATED WITH DICLOFENAC SODIUM 
0-0 AND IN FOUR CONTROL RABBITS . • 
15 30 60 
Time (minutes) 
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TABLE III 
INHIBITORY EFFECTS OF FLUFENAMIC ACID ON THE ACTION OF TOPICALLY INSTILLED SODIUM ARACHIDONATE 
Intraocular Pressure recorded Percentage 
at IS, 30 and 60 minute Increase Inhibition of intervals after instillation in 3 Intraocular Resting of 1% Sodium Arachidonate Pressure % Aqueous Pressure 2 I.O.P. mmHg Increase Protein 
= 100[1 - ~~J Pretreatment mm Hg (Xl) 15 min 30 min 60 min (X2) (x2-XI) in LO.P . g % 
CONTROL I 
RABBITS (8) 
Sterile normal 4 
saline 23,0 :6,8 50,8 :9,4 48,S :8,4 37,0 :5,5 14,0 :5,2 60,9% 1,64 
TEST = 100[1 -~] 
RABBITS (8) 60,9 
Flufenamic acid = 89% 
10 mg per kg. 30,0 :8,6 38,0 :10,9 41,0 :10,4 32,0 :6,3 2,0 ::!:8,4 6,7% 0,61 
-
, 
- --- -
Number of animals in parenthesis. 
Pt and Pc are % increases in the I.O.P. of the drug treated and control groups of rabbits respectively . 
Pooled samples were used to estimate protein. 
Standard deviation. 
(P < 0,005) 
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(P < 0,005) 
INTRAOCULAR PRESSURE READINGS IN EIGHT 
TEST RABBITS PRETREATED WITH FLUFENAMIC 
ACIDQ-OAND IN EIGHT CONTROL RABBITS . • 
Time (minutes) 
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TABLE IV 
INHIBITORYEFFECTSOF SULINDAC ON THE ACTION OF TOPICALLY INSTILLED SODIUM ARACHIDONATE 
Intraocular Pressure recorded Percentage 
at 15, 30 and 60 minute Increase Inhibition of intervals after instillation in 3 Intra-ocular Resting of 1% Sodium Arachidonate Pressure % Aqueous Pressure 2 I.O.P. mm Hg Increase Protein 
= 100[1 - ~}J Pretreatment mm Hg (x 1) 15 min 30min 60 min (x 2) (x2-x l) in I.O.P. g % 
CONTROL 1 
RABBITS (4) 
Sterile normal 4 
saline 22,0 !2,3 49,5 !6,' 50,0 !7,1 41,5 !6,0 19,5 !5,7 88,6% 2,7 
TEST 
= 100 [1 _ 18,3] RABBITS (4) 88,6 
Sulindac = 79,4% 
3 mg per kg 23,3 !2,1 34,8 !7,4 39,0 !4,8 27,5 !6,8 4,2 !5,1 18,3% 1,0 
L- __ __ 
-- ,-- -- - - --
1 Number of animals used in parenthesis . 
2 Pt and Pc are % increases in the I.O.P. of the drug treated and control groups of rabbits respectively. 
3 Pooled samples were used to estimate protein. 
4 Standard deviation. 
(P < 0,005) 
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(P < 0 , 005) 
INTRAOCULAR PRESSURE READINGS IN FOUR TEST 
RABBITS PRETREATED WITH SULINDAC (}---{) 
AND IN FOUR CONTROL RABBITS . • 
15 30 60 
Time (minutes) 
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TABLE V 
INHIBITION OF CARRAGEENAN - INDUCED OEDEMA IN THE RAT PAW BY INDOMETHACIN 
3 Percentage Paw Mass Paw Mass Paw Mass Increase % Inhib i tion 2 Paw Mass at at at at in Mass In= 
= 100[1 - ~ Pretreatment Injection Time 1 Hour (xl) 2 hours 3 hours (X2) (X2-xl) crease 
CONTROL 1 
RATS (11) 
Steri Ie normal 4 
saline 19,97g ;:2,3 21,15g ;:2,5 21,76g ;:2, 22,5g ;:3,1 1,35g ;:1,0 6,38% 
TEST = 100[1 _ ,41 
RATS ( 12) 6,38 
--
Indomethacin = 92,6% 
4 mg per kg. 18,13g :1,2 19,28g ;:2,0 19,36g :2,2 19,37g :2,0 ,09g ;:0. ,47% 
---- -- ----- ---
-----_ .. _- - -
- - - - --- - -- ----- '---- -
Number of animals used in parenthesis. 1 
2 Mt and Mc are % increases in paw mass of the drug treated and control groups of rats respectively, 
(increase in mass is taken as being proportional to an increase in volume) . 
3 The increase in paw mass is measured between one hour and three hours. 
4 Standard deviation. 
(P < 0,005) 
FIG.13. 
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(P < 0,005) 
INCREASE IN PAW MASS IN TWELVE TEST 
RATS PRETREATED WITH INDOMETHACIN 4mg PER kg 
0-0 AND IN ELEVEN CONTROL RATS . • 
1 2 3 
Time (hours) 
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TABLE VI 
INHIBITION OF CARRAGEENAN - INDUCED OEDEMA IN THE RAT PAW BY DICLOFENAC SODIUM 
3 ~ercentage 2 Paw Mass Paw Mass Paw Mass Increase % 
Paw Mass at at at at in mass In= Inhibit ion 
Pretreatment Injection time 1 hour (xl) 2 hours 3 hours (X2) (X2-XI) crease F 100 [1 - :n 
CONTROL I 
RATS (8) 
Sterile normal 4 
saline 20,19g ::!:3,2 22,57g ::!:3,2 24,3g ::!:3,4 26,33g ::!:4,0 3,76g::!:l, 16,66" 
TEST = 100[1 _ 2 '~3~ 
RATS (8) 16 ,06 
--
Diclofenac 18,97g ::!:1,8 20,97g ::!:1,6 21,2g ::!:l,6 21,5g ::!:1,6 0,53g::!:0 , 7 2,53% = 84,8% 
Sodium 
1 mg per kg. 
Numbe r of animals used in parenthesis . 
Mt and Mc are % increases in paw mass of the drug treated and contro l groups of rats respectively, 
(increase in mass is taken as being proportional to an increase in vo lume ). 
The increase in paw mass is measured between one hour and three hours. 
Standard deviation. 
(P < 0,005) 
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FIG.14. INCREASE IN PAW MASS IN EIGHT TEST RATS 
PRE- TREATED WITH DICLOPHENAC SODIUM Img PER kg 
0-0 AND IN EIGHT CONTROL RATS • • 
1 2 3 
Time (hours) 
(P < 0,005) 
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TABLE VII 
INHIBITION OF CARRAGEENAN - INDUCED OEDEMA IN THE RAT PAW BY FLUFENAMIC ACID 
Paw Mass 3 % Paw Mass Paw Mass Increase Percentage 
Paw Mass at at at at in mass In= Inhibition 2
J Pretreatment Injection Time 1 hour (xI> 2 hours 3 hours (X2) (X2-XI) crease = 100 ~ _ mt mc 
CONTROL 
RATS (11)1 
Sterile Normal 4 
Saline 19,97g ::2,3 21,15g ::2,5 21,76g ::2,6 22,5g ::3,1 1,35 ::1,0 6,38% 
TEST =100t_ O,7U 
RATS (12) 6,38 
Flufenamic = 88,7% 
Acid 
10 mg per kg. 18,82g::1,5 19,43g ::1,6 19,64 ::1,6 19,57g ::1,5 0,15 ::0,3 0,72% 
- -- -
Number of animals used in parenthesis 
2 Mt and Mc are % increases in paw mass of the drug treated and control groups of rats respectively 
(increase in mass is taken as being proportional to an increase in volume) 
3 
4 
The increase in paw mass is measured between one hour and three hours 
Standard deviation. 
(P < 0 ,005) 
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FIG.15. 
(P < 0,005) 
INCREASE IN PAW MASS IN TWELVE TEST RATS 
PRETREATED WITH FLUFENAMIC ACID lOmgPER kg. 
0-OAND IN ELEVEN CONTROL RATS . • 
1 2 3 
Time (hours) 
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TABLE VIII 
INHIBITION OF CARRAGEENAN - INDUCED OEDEMA IN THE RAT PAW BY SULINDAC 
3 [P ercentage Paw Mass Paw Mass Paw Mass Increase % Inhib i tion 2 Paw Mass at at at at in mass In= 
F 100 [ 1 - :~j Pretreatment Injection time 1 hour (xl) 2 hours 3 hours (X2) (XrXI) Frease 
CONTROL 
RATS (8) I 
Sterile normal 4 
saline 20,19g ::3,2 22,57g ::3,2 24,3g :,:3,4 26,33g :,:4,0 3,76g :,:1,3 16 , 66% 
= 100[1 - l~:~~ TEST RATS (8) 
Sulindac = 70% 
3 mg per kg. 19,48g :,:1,5 21,72g :,:2,2 22,6g ::2,9 22,80g ::3,3 1,08g ::1,6 4,97 % 
Number of animals used in parenthesis. I 
2 Mt and Mc are % increases in paw mass of the drug treated and control groups of rats respectively, 
(increase in mass is taken as being proportional to an increase in volume). 
3 The increase in paw mass is measured between one hour and three hours. 
4 Standard deviation. 
(P < 0,005) 
FIG .16 . 
25,0 
~ 
c& 
~ 
'" 
'" 
'" 
22,5 :>: 
;. 
'" '" 
20,0 
(P < 0,005) 
INCREASE IN PAW MASS IN EIGHT TEST RATS 
PRETREATED WITH SULINDAC 3mg PER kg ()---() 
AND IN EIGHT CONTROL RATS • • 
1 2 3 
Time (hours) 
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1+++++1 +++++ 
PERCENTAGE INHIBITION OF INTRA-OCULAR 
PRESSURE AFTER PRETREATMENT WITH ANSAI 
COMPOUNDS 
Indomethacin 
4 mg per kg. 
Dic10fenac sodium 
1 mg per kg. 
75 
111I111l F1ufenamic acid 10 mg per kg. 
Sulindac 
3 mg per kg. 
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FIG.18. PERCENTAGE INHIBITION OF CARRAGEENAN-
INDUCED OEDEMA IN THE RAT PAW AFTER 
PRETREATMENT WITH ANSAI COMPOUNDS 
I+++++j 
+++++ 
Indomethacin 
4 mg per kg . 
Dic10fenac sodium 
1 mg per kg. 
76 
f 1IIIIII Flufenamic acid 
10 mg per kg . 
Su1indac 
L...::.oo.::..':"';:.....:J 3 mg pe r kg . 
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FIG.19. A COMPARISON OF THE PROTEIN CONTENT OF THE AQUEOUS 
HUMOUR AFTER PRETREATMENT WITH ANSAI COMPOUNDS 
A B C D E 
I II III 
CONTROL RABBITS (24)1; Groups A, C, E and G 
PRETREATED RABBITS Groups B, D, F and H 
F 
I Rabbits in group B (8) were pretreated with 
4 mg per kg. 
G 
Indomethacin 
H 
IV 
II Rabbits in group D (4 ) were pretreated with Diclofenac sodium 
I mg per kg. 
III Rabbits in group F (8) were pretreated with FIufenamic acid 
10 mg per kg. 
IV Rabbits in group H (4) were pretreated with Sulindac 
3 mg per kg. 
Number of rabbits used in parenthes is. 
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FIG.20. COMPARISON OF THE TWO TEST SYSTEMS 
1 2 
Indomethacin 
'-!....!-~...:..J. I, rug per kg. 
3 4 5 6 
11111111 
7 8 
Flufenamic acid 
10 mg per kg. 
Diclofenac sodium 
1 mg per kg . 
Sulindac 
3 mg per kg. 
COLUMNS 1,3,5 and 7 
COLUMNS 2,4,6 and 8 
Percentage inhibition of the elevation 
of intra-ocular pressure in the rabbit 
Percentage inhibition of oedema in the 
rat paw. 
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CONCLUSION 
The four ANSAI compounds showed a similar degree of 
activity in both the rabbit eye test system and the 
rat paw oedema methods of determining anti-inflammatory 
action. Indomethacin was equally effective in both 
systems, while the other three compounds viz. diclofenac 
sodium, flufenamic acid and sulindac, had a slightly 
greater effect on the rabbit eye test system. (See Fig 20 Pg 78 
i.e . comparison of results) . 
Results obtained suggest that the rabbit eye test system 
has a number of advantages over the rat paw oedema method 
as an in vivo test system for the determination of anti-
inflammatory activity of acidic non-steroidal anti-
inflammatory (ANSAI) compounds: 
(i) ~n the rabbit-eye-test system the responses 
to the inflammagen are large allowing an 
accurate assessment of effectiveness of the 
compound being evaluated; 
(ii) two parameters can be measured, viz. I.O.P. 
and the protein content of aqueous humour, 
compared to one, viz. the increase in volume 
in the rat paw; 
(iii) there is no injection trauma. An advantage 
of the rabbit eye test system is that the 
inflammatory agent is instilled into the eye 
whereas the carrageenan has to be injected 
into the rat paw; 
79 
(iv) the rabbit eye test system is more specific. 
The mode of action of ANSAI compounds probably 
i nvolves the inhibition of the synthesis of 
prostaglandins. By using sodium arachidonate, 
the prostaglandin precursor, substances which 
inhibit the biosynthesis of the prostaglandins 
can be evaluated for anti-inflammatory effect. 
The rabbit eye test system deserves serious 
consideration as a model for the production 
of an acute inflammation when designing a 
screening programme for the detection of acidic 
non-steroidal anti-inflammatory compounds. 
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SUMMARY 
A study of acute inflammation, with particular 
reference to acute ocular inflammation, has been 
undertaken and the histopathology of acute ocular 
inflammation, caused by sodium arachidonate, has been 
examined. 
Current methods of evaluating non~stero idal 
anti-inflammatory drugs have been scrutinised and 
four categories of assays presented . An t1idealll 
screen1ng programme, as suggested by Swingle, has 
been presented. 
The assay procedur es used ~n this study, v~z. the 
rat-p aw-oedema method and the rabbit eye method 
have been described. 
Carrageenan as a phlogistic agent and its suitability 
as an inflammagen in the rat-paw-oedema method of 
assay, has been discussed. 
A short review has been given on arachidonic acid , 
a precursor of the prostaglandins, and the history, 
biosynthesis and mechanism of action of the 
prostaglandins presented. Russel l et al (1975) 
The role of the prostaglandins, with part icu lar 
reference to ocular inflammation, has , been reviewed 
with reference to the effect of prostaglandins on 
intra-ocular pressure. 
The carrageenan-induced inflammatory response in the 
rat-paw has been examined, and the possible involvement 
81 
of prostaglandins in the secondary phase of swelling, 
has been considered . 
A classical non-steroidal anti-inflammatory agent has 
been defined and a hypothetical receptor proposed 
(Scherrer et al 1964) (Shen 1965). A possible 
conformation of prostaglandin E2 has been compared 
with that of indomethacin. The inhibi tion of 
prostaglandin synthesis has been studied and four 
prostaglandin synthetase inhibitors were discussed. 
The acidic non-steroidal anti-inflammatory (ANSAI) 
compounds studied were indomethacin, diclofenac 
sodium, flufenarnic acid and sulindac. 
A description of the experimental procedures used 
for the determination of the two parameters, viz . 
intra-ocular pressure and the protein content of 
aqueous humour of the eye of the anaesthetized albino 
rabbit, have been given. The methods in solubilizing 
the four ANSAI compounds have been discussed. The 
anaesthetic used and the method of producing anaesthesia 
has be en explained . The Mackay- Marg tonometer has been 
discussed and the interpretation of a tonogram studied. 
The technique necessary to obtain legible tonograms was 
presented. The aspiration of aqueous humour has been 
described and the method of protein determination given. 
The experimental detail of rat paw oedema method of 
assay has been described. Sedation of the rats with 
thiopentone sodium has been discussed. Hall and 
Hallet's method fo r measurement of paw volume was also 
presented. 
82 
REFERENCES 
A 
Ambache, N., Brummer, H.C., A simple chemica l procedure 
for distingui , hing E from F prostaglandins with 
applic ation to tissue extracts. Brit. J. 
Pharmac.ol. Chemotherapy, E, 162 170 (1968). 
Ambache, N., Kavanagh, L., Whiting, J. Effect of Mechanical 
Stimulation on rabbits! eyes, release of active 
substance in anterior chamber perforates. J. Physiol. 
176, 378-408 (1965). 
Ariens, E.J. In: "Drug Design" (E.J. Ariens, Ed . ) Vol!. 
New York. Academi c Press. 1971 p . 16 2-193. 
Arrigoni-Martelli, 
~, 134 
E., and Conti, I . 
(1964 ) 
Farmaco, Ed. Prato 
Beitch, 
B 
B.R . Eakins, K. E. The effects 
the I . O.P. of the rabbit . 
158-167. (1969) . 
of prostaglandins on 
Br . J . Pharmacol. ~, 
Bergstrom, S., Ryhage, R., Samuelsson , B., and Sjovall, J . 
Prostaglandins and Related factors, 15. The 
Structures of Prostaglandins El, Fla, and F18. 
J . Biol. Chern . 238, 3555-3564 (1963) 
Bethel, R.A. and Eakins, K. E. The 
of experimentally induced 
polyphoretin phosphate. 
(1972). 
mechanism of the antagonsim 
ocular hypertension by 
Exp. Eye Res.~, 83- 91 
Bhattacherjee, P . Release of prostaglandin-like substances 
by Shigella endotoxin and it s inhibition by non-
steroidal anti-inflammato ry compounds . Br . J. Pharmac., 
~, 489- 494 (1975). 
83 
Bhattacherjee, P. and Eakins, K.E. Inhibition of the ocular 
effects of sodium arachidonate by anti-inflammatory 
compounds. Pros taglandins Vol. 9 No.2 pg 177 
(1975). 
Bhattacherjee, P. and Eakins, K.E . Inhibition of the prosta= 
glandin synthe tase systems in ocular tissues by 
indomethacin. Brit. J. Pharmacol. 50 : 227, (1974) 
Chiang, T.S . , and Thomas , R.P . , 
(1972) 
Christ, E.J. and van Dorp, D.A., 
537-545 (1972). 
Cochrane, C.G. and Janoff, A. 
London Academic Press 
c 
Invest. Opthalmol. 11, 169-176 
Biochem. Biophys. Acta 270 
In the inflammatory process III 
(1974) p. 86-155. 
Cohnheim, J. (1889). In : "Lectures on General Pathology", 
p. 248 London: New Sydenham Society. (This is a 
translation of the 2nd edition of Cohnheim's book 
published in 1882). 
Di -Rosa, 
Di-Rosa , 
M., and Sorrentino, L. 
inflammatory effect of 
~, 340 (1968) . 
D 
The mechanism of the 
carrageenan. Eur. J . Pharmac. 
M., Willoughby, D.A. 
drugs. Letters to 
23, 297 (1971). 
Screens for anti-inflammatory 
the editor, J. Pharm . Pharmac, 
Doherty, D.S. and Robinson, B.V. Inflammatory Response to 
carrageenan - Communication J. Pharm. and Pharmac, 
5:2., 701 (1975). 
84 
E 
Eakins, K.E. Increased intra-ocular pressure produced by 
prostaglandins Ej and E2 in the cat eye. Exp. 
Eye Res. lQ, 87-92 (1970). 
Eakins, K.E. Prostaglandins and Prostaglandin synthetase 
Inhibitor : Actions in Ocular Disease. In 
Prostaglandin Synthetase Inhibitors Ed, by H.J. 
Robinson and J.R. Vane. Raven Press New York 
(1974). 
Eakins, K. E. , Whitelocke, R.A.F., Bennett, A and Martenet, 
A.C. Prostaglandin-like activity in ocular 
inflammation. Brit. Med. J. 2, 452-453 (1972). 
F 
Ferreira, S.H. , Moncada, S and Vane, J.R. Indomethacin 
and aspirin abolish prostaglandin release from 
spleen. Nature New Biology, 231 : 237 (1971). 
Ferreira, S.H. and Vane, J.R. Inhibition of prostaglandin 
biosynthesis - an explanation of the therapeu tic 
effects of non-steroid anti-inflammatory agents. 
In : Seminaire Inserm Prostaglandins, p. 345-357 
Paris 1973 
Flower, R., Gryglewski , R., Herbaczynska-Cedro, K. , and 
Vane, J.R. Nature (London) New Biol. 238 
104 (1972). 
Ford-Hutchinson ~ ~ - J . Pharm. and Pharmacol . ~, 
106-112 (1975) . 
Fruh, F., Faigle, J.W., Krupp, P.J., Menasse, R. , Schmid, K. 
p. 17. Personal communication with Ciba-Geigy S.A. 
Literature on Diclofenac sodium (1975). 
G 
Garrattini, S., Jori, A., Bernardi, D., Carrara, C. , Paglialunga, 
S. and Segre, D. Int. Symp. Non-steroidal anti-
inflammatory drugs, Proc., p. 151 (1965). 
85 
Giroud, J.P. and Willoughby, D.A. Ibid., 101, 241 (1970). 
Goodman, L.S. and Gilman, A. 
Therapeutics - 5th 
p. 643 . 
The Pharmacological Basis of 
Edition N. Y. MacMillan 1975 
Gryglewski - Copernicus Academy - PG and PG synthesis inhibitors 
in inflammation. In report by Prof. W.P. Leary on 6th 
International Congress of Pharmacology (1975). 
H 
Hall, J.M., Hallett , C. A simple precise method for measuring 
rodent paw volume. Communications J . Pharm . Pharmac. 
'Q, 623 (1975). 
Ham, E.A . , Cirillo, V.J., Zanetti, M., Shen, T.Y . and Kuehl, F.A . 
In : "Prostaglandins in Cellular Biology" (P. W. Ramwell 
and B.B. Phariss eds.) p. 345-352 Plenum New York 
(1972) . 
Hamberg, M. , and Samuels son, B. On the mechanism of the 
biosynthesis of prostaglandin Ej and Fj~. J. Biol . 
Chem . 242 , 5336-5343 (1967). 
Hamberg, M. and Samuelsson, B. Detection and isolation of an 
endoperoxide intermediate in prostaglandin synthesis 
Proc. Natn. Acad . Sci . U.S . A. 2Q, 899-903 (1973). 
Hichens In Vitro properties. Anti-inflammatory agents. 
Chemistry and Pharmacology Vol . II . Scherrer and 
Whitehouse Academic Press 1974 p . 285. 
Hicks , R. Inflammation and Repair in Damaged Tissue. Brit. 
Pharmaceutical Journal Sept. 6, 1975 . 
Higgs , G.A. , and Youlten, L.J.F. Prostaglandin production by 
r abbit peritoneal polymorphonuclear leucocytes i n vitro 
Br. J . Pharmac. 44, 330 P. (1972) . 
K 
Kaley, G and Weiner, R., 1971 Ibid . 234 114-115 (1971). 
Kelly, R.G .M ., and Starr, M. S. Effect s of prostaglandins and a 
prostaglandin antagonist on intra-ocu lar pressure and 
protein i n the monkey eye. Canad. J . Ophtha1, ~ 
205-210 (1971). 
86 
Klenberg, D., and Samuelsson , B. The biosynthesis of 
prostaglandin Ej studied with specificially 3H-
labelled 8, II, 14-eicosatrienoic acids. ~ 
Chern. Scand. 12, 534-535 (1965). 
Krupp, P.J., Jacques, R., Menasse, R., Wilhelmi, G. and 
Ziel, R. Int. Congr. Pharmacol. 5th. Abstract 
No. 782 (1972). 
Krupp, P.J., Menasse, R. and R. Ziel. 
Pharmacology of Diclofenac 
by Ciba Geigy Labs.) 1975. 
Chemistry and 
(Literature supplied 
Kuehl, F . A. Jr. Prostaglandins, cyclic nucleotides and cell 
function. Prostaglandins~, 325-340 (1974). 
Ku, E.C., Wasvary, J.M., Cash, W.D . Diclofenac sodium (GP 45840 
Voltaren) A potent inhibitor of prostaglandin synthetase 
Biochemical Pharmacology Vol. 24 Printed in Great Britain 
Pergamon Press1975 : 641-643 . 
M 
Masuda, K., Nippin Ganka Gakkai Zasshi 76 : 664-668 (1972) . 
McCall, E., and Youlten, L. J.F. 
98-100 (1973). 
J. Physiol. London 234, 
McCandless, E.L. Fed. Proc . Fed. Amer. Soc. Exp. BioI. ~, 
166 (1962). 
McCandless, E.L. and Lehoczky-Mona, J. Growth~, 143 (1964) 
Menkin, V. "Dynamics of Inflammation" : MacMillan, New York 
(1940) . 
Miles, A.A . In: "Wound healing" C. Illingsworth London 
Churchill 1966 3p 
Moncada, S., Ferreira, S.H. , Vane J.R. 
217 (1973) . 
p 
Nature London, 246, 
Piper, P . J., Vane J.R. Nature, London, 223 29 ( 1969) . 
87 
R 
Rocha e Silva M., and Gar cia Lerne, J. "Chemical Mediators 
of the acute inflammatory reaction" . Pergamon 
Press. Inc. 1972: 199-229. 
Rodger, A.F. , Whitelock, M. B. , Eakins, K.E. 
in the anterior uvea of the rabbit 
prostaglandins - Arch. Ophthalmol, 
Vascular changes 
produced by 
89 495-499 (1973) . 
Russell, P . T. , Eberle, A. J . , Cheng, H. C. The Prostaglandins 
in Clinical Medicine . A developing role for the 
Clinical Chemist . J. Clinical Chemistry 21/6, 
653-666 (1975). 
s 
Samuels son et aI, Role of PG endoperoxides in human platelets 
From Report on 6th Int. Congress of Pharmacology 1975 
(Report by Prof. W. P. Leary). 
Scherrer, R.A . Chemistry of anti-inflammatory agents in 
"Anti-inflammatory Agents - Chemistry and Pharmacology" . 
Vol . I eds. Scherrer and Whitehouse. N. Y. Academic 
Press (1974) 33- 56. 
Scherrer, R. A. , Winder, C.li., and Short, F . W. Nat. Med. Syrnp. 
lla-lli Amer . Chern. Soc . Div . Med. Chern. Abstract 
(1964). 
Schwartz, H. J . and Kellermeyer, R.W. Carrageenan and delayed 
hypersensitivity. Activation of Hageman factor by 
carrageenan and its possible significance. Froe. 
Soc. Exp. Bio!. Med., 132, 1021 (1969). 
Serafini-Cessi, F. and Cessi, C. Chromatographic separation 
of an inhibitor reversibly associated with fibrinolysin 
in the serum of the guinea pig. Experientia~, 
357 (1963). 
Sevitt, S. Journal of Pathology and Bacteriology, 22, 27 
(1958) . 
Shen, T.Y. (1965) Int. Symp. Non-steroidal Anti-inflammatory 
Drugs Proc . p. 13-20 (1964) 
Smith, M.J., Ford-Hutchinson, A. W., Elliott, P . N.C . , Bolam, J . P. 
J. Pharm. and Pharmac., 26, 692-698 (1974). 
Smith, D. B., O'Neill, A.N. and Perlin, A. S. 
~,1352 (1955) 
Can . J. Chern. 
Smith, J.B . and Willis , A.L. Aspirin selectively inhibits 
prostaglandin production 1n human platelets. 
Nature New Biology, 231 p. 235 (1971). 
88 
Spector, W.G. and Willoughby, D.A. 
of Inflammation" London 
Press Ltd. (1968) . 
In : "The Pharmacology 
- The English University 
Starr, M.S. Exp. Eye Res. 11: 161-177 (1971) 
Steinberg, D., Vaughan, M. , 
prostaglandins on 
free fatty acids. 
(1964). 
Nestel, P.J. et al. Effects of 
hormone-induced mobilization of 
J. Clin. Invest.~, 1533-1540 
Stone, C. A., van Arman, C. G., Peck, H.M ., Minsker, D.H., Ham, 
E.A. Pharmacologic and Toxicologic actions of PG 
synthetase inhibitors. Potential role of PG synthetase 
blockade. In PG synthetase Inhibitors. H.J. Robinson 
and J .R . Vane. New York. Raven Press. (1974). 
Straughan , J.L. University of Stellenbosch - Faculty of Medicine 
Personal correspondence (1975). 
Swingle, K. F . Evaluation for anti-inflammatory activity. 
In : Anti-inflammatory agents - Chemistry and 
Pharmacology. Scherrer and Whitehouse Vol. II 
N. Y. Academic Press 1974, 34-63. 
T 
Tomlinson, R.V., Ringold, H.J., Qureshi, M.C. and Forchielli, E. 
Biochem. Biophys. Res . Commun. 46, 552 (1972). 
Trevor-Roper, P.D. In: "Ophthalmology"- a text book for diploma 
students - 2nd edition, London: Lloyd-Luke (Medical 
Books) Ltd. 4,7,8,91,93,95 and 535. (1962). 
v 
van Arman, C.G., Risley, E.A. and Kling, P.J. (1971) 
Pharmacologist 1l, 284 (1971). 
Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism 
of action for aspirin-like drugs, Nature (London) 
New BioI. 231, 232 (1971). 
Vinegar, R., Macklin, A., Traux, J.F., and Selph, J.L. 
Pharmacologist, 1l, 284 (1971). 
89 
Vinegar, R., Schreiber, W., and Hugo, R. J . Pharmaco1. Exp . 
Ther . 166, 96 (1969) . 
Vogt, W. 1974 Pharmac . Review~, 125-169 (1974) 
w 
Waitzman, M.B. and King, C. D. Prostaglandin influences on 
I . O.P . and pupil s~ze . Am. J . Physiol. 212 
329-334 (1967) 
Wa lter and Israel "General Pathology" - 4th Ed . 1974 69-83 
Willis , A,L. In Prostaglandins, Pep tides and Amines ed. by 
Mantegazza, P , a nd Horton, E.W . London.Academic 
Press (1969) 
Winder, C.V ., Wax, J, 
Ther . 112, 
and Been, M.A. 
174 (1957) 
Arch, Int. Pharmacodyn. 
Winder, C. V., Wax, J., Serrano, B., Jones, E.M . and McPhee, M.L. 
Arthritis Rheum .~, 36 (1963) 
Winter, C.A., Risley, E. A. 
BioI. Med. 111, 
and Nuss, G. W. 
544 (1962) 
Proc . Soc. Exp. 
Winter, C. A., Risley E.A., and Nuss, G.W. Anti-inflammatory 
and antipyretic activities of i ndomethacin . 
J. Pharmac. Exp ., Ther. 141 , 369-376 (1963) . 
Whitehouse, M. W., "Regulation of Inflammation and the immune 
response". In : Anti- inflaunnatory agents -
Chemi stry and Pharmacology - Scherrer and Whitehouse 
N.Y. Academic Press 1974 p . 4 and 22 
Wiseman, E. H. Drug Kinetics of anti-inflammatory agents . 
In : Anti-inflammatory Age nts - Chemistry and 
Pharmacology Vol. II. Scherrer and Whitehouse 
N. Y. Academic Pre s s 1974 p.235 . 
90 
APPENDIX I 
INDEX TO PHOTOGRAPHS 
P 1 Injecting carrageenan into the plantar 
area of the rat-paw . 
P 2 Measuring paw mas s . 
P 3 Probe used to measure intra-ocular pressure. 
P 4 Measurement of intra-ocular pressure 
Probe protected by a rubber membrane. 
P 5 Mackay-Marg tonometer showing a tonogram. 
P 6 Aspirat i ng the rabbit eye . 
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P1 
P6 
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APPENDIX II 
HISTOLOGICAL OBSERVATIONS OF THE SODIUM ARACHIDONATE-
INDUCED INFLAMMATORY RESPONSE IN THE RABBIT EYE 
I Diagram of anterior section of the eye shmving 
the areas (0) which were exami ned 
microscopically. 
II Region of aqueous veins with polymorphonuclear 
leucocyte infiltration. 
III Normal Tissue - Before the induction of 
inflammation (low magnification) . 
IV Capillary dilation , congestion and interstitial 
oedema after the administration of sodium 
arachidonate (high magnification) . 
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APPENDIX III 
HISTOLOGICAL OBSERVATIONS CONTINUED: 
P 1 
P 2 
3 
4 
A section of the angle of conjunctival 
reflection is shown before the administration 
of sodium arachidonate. 
Show magnified sections of the angle of the 
conjunctival reflection after the administration 
of sodium arachidonate. The inflammatory 
response has occurred, and interstitial oedema, 
polymorphonuclear infiltration, vascular 
dilatation and congestion can be seen. 
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APPENDIX IV 
HISTOLOGICAL OBSERVATIONS CONTINUED: 
P 1 
P 2 
3 
4 
A sect ion of the Ci liary Body is shown 
before the administration of sodium 
arachidonate . The nuclei of the 
endothelial cells, nuclei of the supporting 
mesenchymal cells and a few polymorphonuclear 
cells can be seen. 
These show magnified sections of the Ciliary 
Body after the administration of sodium 
arachidonate . The inflammatory process has 
occurred and vascular dilatation, vascular 
engorgement and interstitial oedema can be 
seen. 
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P 4 
(Magn i fication x 400 ) 
Ciliary Body (before the induction of inflammation) 
